0001161697-12-000829.txt : 20121107 0001161697-12-000829.hdr.sgml : 20121107 20121107140849 ACCESSION NUMBER: 0001161697-12-000829 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20120831 FILED AS OF DATE: 20121107 DATE AS OF CHANGE: 20121107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REPRO MED SYSTEMS INC CENTRAL INDEX KEY: 0000704440 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 133044880 STATE OF INCORPORATION: NY FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-12305 FILM NUMBER: 121186064 BUSINESS ADDRESS: STREET 1: 24 CARPENTER RD CITY: CHESTER STATE: NY ZIP: 10918 BUSINESS PHONE: 9143438499 MAIL ADDRESS: STREET 1: 24 CARPENTER RD CITY: CHESTER STATE: NY ZIP: 10918 10-Q/A 1 form_10-q.htm FORM 10-Q/A FOR 08-31-2012

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

Amendment No. 1

 

(Mark One)

 

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended August 31, 2012

 

or

 

[  ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________.

 

Commission File Number: 0-12305

 

REPRO-MED SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

 

New York

13-3044880

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

24 Carpenter Road, Chester New York

10918

(Address of principal executive offices)

(Zip Code)

 

(845) 469-2042

(Registrant’s telephone number, including area code)

 

n/a

(Former name, former address, and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  [X] Yes [  ] No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   [X] Yes [  ] No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

 

Large accelerated filer [  ]

Accelerated filer [  ]

 

 

 

 

Non-accelerated filer   [  ]

(Do not check if a smaller reporting company)

Smaller reporting company [X]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  [  ] Yes [X] No

 

As of October 12, 2012, 36,661,667 shares of common stock, $.01 par value per share, were outstanding.



EXPLANATORY NOTE


The purpose of this Amendment No. 1 to the Quarterly Report on Form 10-Q for the period ended August 31, 2012 (“Form 10-Q”) is to submit Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T. Exhibit 101 consists of the Interactive Data Files relating to our Form 10-Q for the quarterly period ended August 31, 2012, filed with the Securities and Exchange Commission on October 15, 2012.


PART II – OTHER INFORMATION

 

ITEM 6.  EXHIBITS.

 

 

31.1 *

Certification of Principal Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act 2002

 

 

 

 

31.2 *

Certification of Chief Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act 2002

 

 

 

 

32.1 *

Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act 2002

 

 

 

 

32.2 *

Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act 2002

 

 

 

 

101 **

Interactive Data Files of Financial Statements and Notes.

 

* Previously filed.

 

** In accordance with Regulation S-T, the Interactive Data Files in Exhibit 101 to the Quarterly Report on Form 10-Q shall be deemed “furnished” and not “filed”.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

REPRO-MED SYSTEMS, INC.

 

 

November 7, 2012

/s/ Andrew I. Sealfon

 

Andrew I. Sealfon, President, Chairman of the Board, Director, Principal Executive Officer

 

 

November 7, 2012

/s/ Michael R. Boscher

 

Michael R. Boscher, Treasurer and Chief Financial Officer


Page 2

 EX-101.SCH 2 repr-20120831.xsd XBRL SCHEMA FILE 002 - Statement - BALANCE SHEETS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 003 - Statement - BALANCE SHEETS (PARENTHETICAL) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 001 - Document - Document and Entity Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 102 - Disclosure - INVENTORY link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 105 - Disclosure - LONG-TERM DEBT link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 201 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 101 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40101 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 103 - Disclosure - PROPERTY AND EQUIPMENT link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 104 - Disclosure - RELATED PARTY TRANSACTIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 107 - Disclosure - SALE-LEASEBACK TRANSACTION - OPERATING LEASE link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 005 - Statement - STATEMENTS OF CASH FLOWS (UNAUDITED) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 106 - Disclosure - STOCK OPTIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 004 - Statement - STATEMENTS OF OPERATIONS (UNAUDITED) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink EX-101.INS 3 repr-20120831.xml XBRL INSTANCE FILE false --02-28 Q2 2013 2012-08-31 10-Q 0000704440 36661667 Smaller Reporting Company REPRO MED SYSTEMS INC <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div style="WIDTH: 720px"><!--StartFragment--> <p style="MARGIN: 0px"><u>BASIS OF PRESENTATION</u></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">The accompanying unaudited financial statements as of August 31, 2012 have been prepared in accordance with generally accepted accounting principles in accordance with instructions to regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial presentation.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">In the opinion of the Company&#39;s management, the financial statements contain all adjustments (consisting of normal recurring accruals) necessary to present fairly the Company&#39;s financial position as of August 31, 2012 and the results of operations and cash flow for the three-month and six month periods ended August 31, 2012 and 2011.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">The results of operations for the three months and six months ended August 31, 2012 and 2011 are not necessarily indicative of the results to be expected for the full year. These interim financial statements should be read in conjunction with the financial statements and notes thereto of the Company and management&#39;s discussion and analysis of financial condition and results of operations included in the Company&#39;s Annual Report for the year ended February 29, 2012, as filed with the Securities and Exchange Commission on Form 10-K.</p> <!--EndFragment--></div> </div> 263700 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div style="WIDTH: 720px"><!--StartFragment--> <p style="MARGIN: 0px"><u>LEASED AIRCRAFT</u></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">The Company leases an aircraft from a Company controlled by the president. The lease payments aggregated were $5,375 for the three-months ended August 31, 2012 and 2011 and $10,750 for the six months ended August 31, 2012 and August 31, 2011. The original lease agreement has expired and the Company is currently on a month-to-month basis for rental payments.</p> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div style="WIDTH: 720px"><!--StartFragment--> <p style="MARGIN: 0px"><u>THE NATURE OF OPERATIONS</u></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">Repro-Med Systems, Inc. (the "Company") designs, manufactures, and markets proprietary medical devices primarily for the ambulatory infusion market and emergency medical applications. The FDA regulates these products.</p> <!--EndFragment--></div> </div> P2Y P1Y 0.18 112504 199527 962154 884727 107547 153800 3512294 3263244 21456 17718 5211276 4805145 4311633 4253536 1684369 1757223 1322250 1708780 -72854 386530 0.01 0.01 50000000 50000000 38936667 37471667 36661667 35196667 389367 374717 666235 493064 1303597 1033249 1409615 1183330 3007659 2345339 263700 121363 121363 255356 255228 30968 28156 42933 23959 83470 46278 0.01 0.01 0.01 0.01 0.01 0.01 56540 41551 202076 109838 170640 -3572 1375 -6585 11266 532440 197339 670075 536557 113000 3125 181796 79266 229092 220525 -87023 13864 77427 -105238 -46253 77791 116092 -18449 14989 19631 83929 421743 -2812 -30533 -7488 23315 24513 7179 7823 14386 15899 14386 15899 1251385 1167456 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div style="WIDTH: 720px"><!--StartFragment--> <p style="MARGIN: 0px"><u>INVENTORIES</u></p> <p style="MARGIN: 0px"><br /> </p> <p style="MARGIN: 0px">Our inventory includes $349,000 of certain subassemblies which did not meet our specifications and were rejected by us and returned to the vendor for correction or replacement.</p> <!--EndFragment--></div> </div> 1198 24900 2932 30342 1219565 1254417 5211276 4805145 557996 558853 661569 695564 375 1474 -21418 303418 -428820 -88676 377384 171788 350644 118073 440983 316032 -9553 18452 -18039 25709 2157 2077 42675 41417 416175 437832 541993 178887 688114 510848 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div style="WIDTH: 720px"><!--StartFragment--> <p style="MARGIN: 0px"><strong>NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"><u>THE NATURE OF OPERATIONS</u></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">Repro-Med Systems, Inc. (the "Company") designs, manufactures, and markets proprietary medical devices primarily for the ambulatory infusion market and emergency medical applications. The FDA regulates these products.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"><u>BASIS OF PRESENTATION</u></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">The accompanying unaudited financial statements as of August 31, 2012 have been prepared in accordance with generally accepted accounting principles in accordance with instructions to regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial presentation.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">In the opinion of the Company&#39;s management, the financial statements contain all adjustments (consisting of normal recurring accruals) necessary to present fairly the Company&#39;s financial position as of August 31, 2012 and the results of operations and cash flow for the three-month and six month periods ended August 31, 2012 and 2011.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">The results of operations for the three months and six months ended August 31, 2012 and 2011 are not necessarily indicative of the results to be expected for the full year. These interim financial statements should be read in conjunction with the financial statements and notes thereto of the Company and management&#39;s discussion and analysis of financial condition and results of operations included in the Company&#39;s Annual Report for the year ended February 29, 2012, as filed with the Securities and Exchange Commission on Form 10-K.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"><u>EMPLOYEE STOCK AWARDS</u></p> <p style="MARGIN: 0px"><br /> </p> <p style="MARGIN: 0px">In July 2012, 1,465,000 shares were authorized to issue to employees as share compensation valued at $0.18 per share, the market value on the date of the board authorization. The value of these shares will be amortized into operations over the one to two year restriction on the shares.</p> <p style="MARGIN: 0px"><br /> </p> <p style="MARGIN: 0px"><u>INVENTORIES</u></p> <p style="MARGIN: 0px"><br /> </p> <p style="MARGIN: 0px">Our inventory includes $349,000 of certain subassemblies which did not meet our specifications and were rejected by us and returned to the vendor for correction or replacement.</p> <p style="MARGIN: 0px"><br /> </p> <p style="MARGIN: 0px"><u>USE OF ESTIMATES IN THE FINANCIAL STATEMENTS</u></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Important estimates include but are not limited to, asset lives, valuation allowances, inventory, and accruals.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"><u>SUBSEQUENT EVENTS EVALUATION</u></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">The Company has evaluated subsequent events through October 15, 2012, the date on which the financial statements were issued.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"><u>EMERGING ACCOUNTING STANDARDS</u></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">Management does not believe that any of the standards adopted by the Financial Accounting Standards Board that have been adopted but are not yet effective will have a material effect on the Company&#39;s financial reporting.</p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px"><u>LEASED AIRCRAFT</u></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">The Company leases an aircraft from a Company controlled by the president. The lease payments aggregated were $5,375 for the three-months ended August 31, 2012 and 2011 and $10,750 for the six months ended August 31, 2012 and August 31, 2011. The original lease agreement has expired and the Company is currently on a month-to-month basis for rental payments.</p> <!--EndFragment--></div> </div> 54283 52669 5375 5375 10750 10750 22481 22481 123656 134895 349000 11239 11240 427692 88676 128 158369 188902 121500 -1000 845360 498940 1019 946 20399 19212 37015 9969 75390 22696 495750 54767 1951608 1362217 3695773 2856187 663432 656338 1545202 1243116 1465000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div style="WIDTH: 720px"><!--StartFragment--> <p style="MARGIN: 0px"><u>EMPLOYEE STOCK AWARDS</u></p> <p style="MARGIN: 0px"><br /> </p> <p style="MARGIN: 0px">In July 2012, 1,465,000 shares were authorized to issue to employees as share compensation valued at $0.18 per share, the market value on the date of the board authorization. The value of these shares will be amortized into operations over the one to two year restriction on the shares.</p> <!--EndFragment--></div> </div> 3991711 3550728 4397411 3692728 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div style="WIDTH: 720px"><!--StartFragment--> <p style="MARGIN: 0px"><u>SUBSEQUENT EVENTS EVALUATION</u></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">The Company has evaluated subsequent events through October 15, 2012, the date on which the financial statements were issued.</p> <p style="MARGIN: 0px">&nbsp;</p> <!--EndFragment--></div> </div> 214092 98000 2275000 2275000 142000 142000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div style="WIDTH: 720px"><!--StartFragment--> <p style="MARGIN: 0px"><u>USE OF ESTIMATES IN THE FINANCIAL STATEMENTS</u></p> <p style="MARGIN: 0px">&nbsp;</p> <p style="MARGIN: 0px">The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Important estimates include but are not limited to, asset lives, valuation allowances, inventory, and accruals.</p> <!--EndFragment--></div> </div> 35551934 36967975 35421253 36824905 35546993 36863808 35371830 36720738 xbrli:shares ISO4217:USD ISO4217:USD xbrli:shares 0000704440 2012-07-01 2012-07-30 0000704440 2012-05-31 2012-08-31 0000704440 2012-03-01 2012-08-31 0000704440 2011-05-31 2011-08-31 0000704440 2011-03-01 2011-08-31 0000704440 2012-10-12 0000704440 2012-08-31 0000704440 2012-07-31 0000704440 2012-02-29 0000704440 2011-08-31 0000704440 2011-02-28 EX-101.CAL 4 repr-20120831_cal.xml XBRL CALCULATION FILE EX-101.LAB 5 repr-20120831_lab.xml XBRL LABEL FILE Amendment Flag Current Fiscal Year End Date Document and Entity Information [Abstract] Document And Entity Information [Abstract]. Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Document Type Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Filer Category Entity Registrant Name Accounts Payable, Current Accounts payable Accounts Receivable, Net, Current Accounts receivable less allowance for doubtful accounts of $21,456 and $17,718 for August 31, 2012 and February 29, 2012, respectively Accrued Liabilities, Current Accrued expenses Additional Paid in Capital, Common Stock Additional paid-in Capital Assets TOTAL ASSETS Assets [Abstract] ASSETS Assets, Current Total Current Assets Assets, Current [Abstract] CURRENT ASSETS: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Common Stock, Value, Issued Common stock, $0.01 par value, 50,000,000 shares authorized and 38,936,667 and 37,471,667 shares issued; 36,661,667 and 35,196,667 shares outstanding at August 31, 2012 and February 29, 2012, respectively. Deferred Compensation Equity Deferred compensation cost Deferred Tax Assets, Net, Current Deferred Tax Asset Deferred Tax Liabilities, Noncurrent Deferred tax liability Deposits Assets, Current Certificates of deposit Deposits Assets, Noncurrent Security deposit Employee-related Liabilities, Current Accrued payroll and related taxes Intangible Assets, Net (Excluding Goodwill) Patents, net of accumulated amortization of $109,838 and $107,640 at August 31, 2012 and February 29, 2012, respectively Inventory, Net Inventory Liabilities Total Liabilities Liabilities and Equity TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current Total Current Liabilities Liabilities, Current [Abstract] CURRENT LIABILITIES Liabilities, Noncurrent Total Other Liabilities Liabilities, Noncurrent [Abstract] OTHER LIABILITIES Notes Payable, Noncurrent Note payable - less current portion Notes Payable, Current Note payable - current portion Notes Payable, Related Parties, Current Notes payable to related parties - current portion Notes Payable, Related Parties, Noncurrent Notes payable to related parties - less current portion Other Assets, Noncurrent Total Other Assets Other Assets, Noncurrent [Abstract] OTHER ASSETS: Other Deferred Credits, Current Deferred capital gain - current portion Other Deferred Credits, Noncurrent Deferred capital gain less current portion Prepaid Expense, Current Prepaid expenses Property, Plant and Equipment, Net PROPERTY & EQUIPMENT, net Retained Earnings (Accumulated Deficit) Retained earnings BALANCE SHEETS [Abstract] Stockholders' Equity Attributable to Parent Total Stockholders' Equity Stockholders' Equity Attributable to Parent [Abstract] STOCKHOLDERS' EQUITY Stockholders' Equity before Treasury Stock Total Stockholders' Equity before Treasury Stock Taxes Payable, Current Accrued tax liability Treasury Stock, Value Less: Treasury Stock, 2,275,000 shares at cost at August 31, 2012 and February 29, 2012 Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment PROPERTY & EQUIPMENT, accumulated depreciation Allowance for Doubtful Accounts Receivable, Current Accounts receivable, allowance for doubtful accounts Common Stock, Par or Stated Value Per Share Common Stock, par value per share Common Stock, Shares Authorized Common Stock, shares authorized Common Stock, Shares, Issued Common Stock, shares issued Common Stock, Shares, Outstanding Common Stock, shares outstanding Finite-Lived Intangible Assets, Accumulated Amortization Patents, accumulated amortization Treasury Stock, Shares Treasury Stock, shares Cost of Goods Sold Cost of goods solds Costs and Expenses Total Costs and Expenses Costs and Expenses [Abstract] COST AND EXPENSES Earnings Per Share, Basic Basic Earnings Per Share, Basic and Diluted [Abstract] NET INCOME PER SHARE Earnings Per Share, Diluted Diluted Foreign Currency Transaction Gain (Loss), before Tax Gain (Loss) currency exchange Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest NET PROFIT BEFORE TAXES STATEMENTS OF OPERATIONS (UNAUDITED) [Abstract] Income Tax Expense (Benefit) Provision for Income Taxes Interest Expense Interest Expense Investment Income, Net Interest and Other Income Net Income Nonoperating Income (Expense) Total other Income/(Expense) Nonoperating Income (Expense) [Abstract] Other Income/(Expenses) Operating Income (Loss) Net Operating Profit Other Nonoperating Income Forgiveness of Interest Research and Development Expense Research and development Revenue, Net NET SALES Selling, General and Administrative Expense Selling, general and administrative Weighted Average Number of Shares Outstanding, Diluted Diluted Weighted Average Number of Shares Outstanding, Basic Basic Weighted Average Number of Shares Outstanding Reconciliation [Abstract] WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash from operating activities: CASH AND CASH EQUIVILENTS, BEGINNING OF PERIOD CASH AND CASH EQUIVILENTS, END OF PERIOD Cash and Cash Equivalents, Period Increase (Decrease) NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Non Cash Activities: Cash Paid During Year For Abstract Cash Paid During Year For [Abstract]. Cash paid during the period for: Conversion of Stock, Amount Issued Conversion of Preferred Stock into Common Stock Deferred Compensation Cost Deferred compensation cost Deferred compensation cost Depreciation, Depletion and Amortization Depreciation and amortization Excess Tax Benefit from Share-based Compensation, Financing Activities Excess tax benefits from share-based payment arrangements Income Taxes Paid Taxes Increase (Decrease) in Accounts Payable Increase (decrease) in accounts payable Increase (Decrease) in Accounts Receivable (Increase) decrease in accounts receivable Increase (Decrease) in Accrued Liabilities Increase (decrease) in accrued expense Increase (Decrease) in Accrued Taxes Payable Increase in accrued tax liability Increase (Decrease) in Deferred Income Taxes Decrease in deferred tax asset Increase (Decrease) in Employee Related Liabilities Increase in accrued payroll and related taxes Increase (Decrease) in Interest Payable, Net (Decrease) in accrued interest Increase (Decrease) in Inventories (Increase) in inventory Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Other Current Liabilities Increase in security deposits Increase (Decrease) in Prepaid Expense Decrease in prepaid expense Interest Paid Interest Net Cash Provided by (Used in) Financing Activities NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES Net Cash Provided by (Used in) Investing Activities NET CASH USED IN INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES Net Cash Provided by (Used in) Operating Activities NET CASH PROVIDED BY OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net Income (Loss) Attributable to Parent Net income Other Noncash Income Deferred capital gain - building lease Payments to Acquire Property, Plant, and Equipment Payments for property and equipment Payments to Acquire Restricted Certificates of Deposit Purchase of certificates of deposit Proceeds from Issuance of Common Stock Proceeds from issuing common stock Proceeds from Sale of Intangible Assets Payments for patents Repayments of Notes Payable Payments on notes payable Repayments of Related Party Debt Payments to note payable to related parties Share-based Compensation Stock based compensation STATEMENTS OF CASH FLOWS (UNAUDITED) [Abstract] Supplemental Cash Flow Information [Abstract] Supplemental Information Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES INVENTORY [Abstract] Inventory Disclosure [Text Block] INVENTORY PROPERTY AND EQUIPMENT [Abstract] Property, Plant and Equipment Disclosure [Text Block] PROPERTY AND EQUIPMENT RELATED PARTY TRANSACTIONS [Abstract] Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS LONG-TERM DEBT [Abstract] Debt Disclosure [Text Block] LONG-TERM DEBT STOCK OPTIONS [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] STOCK OPTIONS SALE-LEASEBACK TRANSACTION - OPERATING LEASE [Abstract] Sale Leaseback Transaction Disclosure [Text Block] SALE-LEASEBACK TRANSACTION - OPERATING LEASE Other Cost and Expense, Operating Aircraft lease expense Other Inventory, Inventory at off Site Premises Inventory of certain assemblies off site Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Shares authorized for issuance Share Based Compensation Arrangement By Share Based Payment Award Restriction Period On Shares Authorized Maximum Shares authorized for issuance, period restriction, maximum Share based compensation arrangement by share based payment award restriction period on shares authorized, maximum. Share Based Compensation Arrangement By Share Based Payment Award Restriction Period On Shares Authorized Minimum Shares authorized for issuance, period restriction, minimum Share based compensation arrangement by share based payment award restriction period on shares authorized, minimum. Share Based Compensation Arrangement By Share Based Payment Award Share Price On Date Of Authorization Shares authorized for issuance, per share Share based compensation arrangement by share based payment award share price on date of authorization. Basis Of Accounting Policy [Policy Text Block] BASIS OF PRESENTATION Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Inventory, Policy [Policy Text Block] INVENTORIES Leased Aircraft [Policy Text Block] LEASED AIRCRAFT The accounting policy related to leased aircrafts. Nature Of Operations [Policy Text Block] THE NATURE OF OPERATIONS The accounting policy related to the nature of operations. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] EMPLOYEE STOCK AWARDS Subsequent Events, Policy [Policy Text Block] SUBSEQUENT EVENTS EVALUATION Use of Estimates, Policy [Policy Text Block] USE OF ESTIMATES IN THE FINANCIAL STATEMENTS EX-101.PRE 6 repr-20120831_pre.xml XBRL PRESENTATION FILE XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 8 0001161697-12-000829-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001161697-12-000829-xbrl.zip M4$L#!!0````(`"-Q9T$#E-=BVAX``"`.`0`1`!P`&F"QB@)^F/`@MP8FQBV57%_/I[CF3`!O.JPN[.W,X\ M4EBOO<]#.I(E^=T_G^<>>60A=P/_?46]5BJ$^>/`H%_CL?<4/*O_\\:]_>?>W:K5U]Z'9'[G_N2)M?WQ->L$3"YE#;I:DI_]Z MT_](9E&T>%.K/3T]72_TYU'H78^#>;6:%$_:)<:U>JW6R?KY(@R<>`P509JF MJ%I55:J:2?Z'U-^H%ND]R(Q8'0'X/G_CN?[O[RNIQD1303BM:8JBUS!Y1#FK M)-E#M@@SV<,YGS/''5-/-AUQQ%G#MA5;5U?EL%;W0#NNCW(:K]MYGD5S+Y/_ M21>YU4:C41.IZZP[%#)9,765U6$;#*)]SL;7T^"Q!@D(6:TJ:G4#.N;5*:6+ M=9$)Y2-1U1T M%%@4)+]LD-UN82C^XX1ZG+VK[32^P70;AR$^=#E8WV=&PY;OW-&("7C[$@M` M6JTJ6E6S)=9][6Y@WP7C>+[.T@/=!LX]/.,"]][4`H#_2Y.8][:Y#S3RV@=Y MG58`8$C7\R"OV]P%+-FD+2,WI1BP27H6VW?8\\]L*8#EIA2`4(%_+,4P#$7BS&UW!W`PGP?^(`K& MOP]F-&2\&T=B"(9A.8W^0#9$8UK[J5!>#2;5U>BJ:KOYL43LNS+[)]E`A3AL M[,ZA5WM?`7)ZO5Y7ZW4K0^T`J&V>]Z['PENPH&D0IM62>5Z`4@;``%H@?;8( MP@B%"J@7U%^FB61`;"/OLZG+085^U*%SEH*>32@`>[_5ZW?)0^N.##X/AJV' M`6EW;M.XLP@D![&/K'N!YXZ7\O^'`.G&`Z4)+J=E+8#= M/[SH+42`=]W;X>=>BV"(1'J?;CZV;TFE6JO]HM_6:G?#._+K3\.'CP3B53($ MIMR-((ZD7JW6ZE1(3A0U[,MP2\7"R9_5*%7RVHD@5JA6_S&-WO[U+XC"<1_Q M!TG^AA!XZ4'4\4O[;OC3&V)IRN*Y@AD2Q(.(AM%]2*?8">]/JM0:LS;`[;W0ZFUN)5OMKBA/KH?/'6'_'%R26& M,T8H:%A8/CI![-/8<2,(O">N#T&82SV,_".&G#BAG`03THRG,8^(KEZ)V)S, MZ",C(\9\L@`KHQC_N[ZH-W0PD"-/;C0C4^8SZ/"\)::P!;9!U\8%)5UH#:(Y MGE<60\(0@G)0%"=10$(VC3V*/\F@^NLU:8K\4(^WO"+1##IX)R!^$$'!L1<[ M0-+S$#DDP:-)$,YE8>B3B`-#KQ?P&/HIJ/>/V$7\H^4><#DL`"_6^\D7@Y%[(U:0%0>A"B#7Q:FX+=$%"]='QHD0DLY.5/=WO?&6 MDSGUZ52H64@P7__HVA3U`^*DSF]@!?+Y]Y``W840%K3@HX`]D.88HDA\!K(* M8Q@R?B`^&S/.*?3UH,9$!&1"W1`DF@\L);%`^NH>,T1E8A50:>Q%(DNP`&5) MJ\'4,>4S,O&")Z$3S!O!I(%58;0"(\,(&^"" M7T&6D`&>K!V+#!L+3ED/>G?,^G[8.-)1+$6$LHGT<8]&X$7@.EK#:F/*[3D"009SH;_`)T&P##)NO4\GE%_ M*MJ;NY((_/<>/(Q`U/;SM@'BDHSO9$Q="$RT3U!NA MZQRHTC#P/!D(8:^$([7K`%'1U6J:S+GS2L99^I$F<0NE/HY;T$,`688H"`D)7C>"9BO57"(/J`TX]EAP")IZ\ MBOD>;;J2&'7E!Q@>N3OU(17BI'A"QV@8\$M&3N'O#/P8*H*I#HLP1DG>AD"Q M1Q=B1)P#S667_77,WE9&R'O7,G7V[F)HF%_A,%L1KFS0."V)E\J:IF*L:[VF&$EV!1/XV% M5M4:N_F/L6@T3,UZ&8L^&S/W$;-U6)3')2]#X7IIU#75S-%+'IA+\RI24[9M M6'F:.HD73-.=CRX=N9Y8==DBE9]:O`4CN1R=0EW)U&U+DM?1;(7K2S=536ND7>LHIB*I%JE+7:OKFO$:JIX7 M/.'2U'T0W@7Q*)K$WJ['9@SWG!*%ZUI3#;.>HG\.N/(E4:A;6Q;&.I>0!.KNHUHUL:AOAZ_-_4BY-M>:?D M+#Y*J-N&7F]LN)T$JWC.Q?8YIJ5I^M?&N:Z=P%F5.RQW\Q_CK&L:S*B^.L[Z M:9S72\7Z67I6;,LN@K-925%3 MS(_C*I;P!;O\P@EOKV]N$]U.O_@XGK>1UE3D/[D4MQ%=EMHEA^NBJ;4YC_?1 MDFFE:$NW&[CSV3I`2:*Y#)VB-:1;AJ5>@,[V)O6CV],+U]-Z>_HIF"_-KG"U MF6KCB!6>PBX5^FT]+'[=#/TH'W]>/'>\=4GXVO\Z8?EVKYJ*,!X MR_C3<%[*H#3[5U5;US-SGLLP*,\'=$6QZF;C\@Q*DM'6V'Q@P_1+ANI7[9'>)CBDSZEWE)W`'Z?6L8]E M*G[Y5U/UNKZKOGV`BN)8Z'+O*SF*,T-\]R5$;DKQ#F>:>OK=82Z*UU,H4B%` M0=/L5U#8L;#\Q.*G'A`*[.5QFD&=0Z50G=CJ?JLZ0"6$2D3O#'][3.Q-\YWF M'`]$I_;CG9*QW##.T!IZID\X#K!H[J4%@!KF_ZJXEQ6Y"74JA'G[3$GPOK]9RV//6T\WKG.^Z&XD4B MTA]*^/D]+@%V&V7^'OYW(]NORN4OJ\>OR MO'QF\X47+!GK,SQ/MF\7]-%\F`)F M^3?,9Q,WN@<3RS].FK6<#[$+RF98K>1*O5T)_QJR00A^[,O&2W&BG8I3E1^HZW\,.+]A M$\@#!BI%N6HJ3'M6\:.E%#I0TKIEXW3>N+:4A4@`=Z4U)=/RMYUYRJ9W:/;X%Y&?KR M#JFHVHZ?'<.>;"1*IK)9#MFTDO?/V:K5J.>PR8*Z#*O21BNKD0G@BB15X@68 M6D-I:"6Q*F_51U/,7'3,I MW4[O[;X8Y2'V6Q?,[&>_ ME;%D-S?JFGG,S;<0%DV^--5;EM50"^&>!%A'>KKMG&6'M?7M$?HXQ.+Y_UGN ML]XO@]4>X52LO4<&.3G_E&_^BI!!B0.`;1B-0WZ0`_$8__VOF_>(87^!DGL% MHV$?%,9^H&7+I+RXL%'7#XX3+Y=)VW]D?A2$^X60RE'V;M>&=M`24L@N3[.\ MC:V::AD'(Z`S>';Q^R#)AI+C]KTG=\D1H&:K!Z.`/2C+$\6?/R+HX7>IW-7Y MO#TBR&8JV0ATQ=0/.D$675&$RQOT+<,^..<[S#>[0Z/#HM8S?I[']:=X&/G) M];R$\_&,Q1_ZTG4ULV1U'%/1=`L]C&28JOY*NN*M1-9X,\_*7?6V5"LS#F>@ MO`Q[>6O;=G81\?78RPR%=;M^8?#EQ:RFW3C7:E(OK#8/O@J9Y[VK.H;Y2XLZ M#[,,))?0"268-P]*.*X-':.=&0DVK9\+M-"]D6K=REQQ?`+0O(\/[4N\O$7_ M?_SF4+OS[U9GV.VW6R_YS!`DCD)2VWPXYX1"W3@D[DJGJP\B%[#?YHTA`.$$8?)I59BTR(](BB]R+3PZ%A_7 M>.4'A(Z9^*XCR*^ARD6JM.-N/2_YE;W:L+-DMN"\CD=YYYZ-1G8/R&6)E/AB MOJ%K!?(H;U^+HAOG$-E>@]A:92CZIA08`E-#[]YUE&,HB[WKQ#2,],URIZ!L M^HZX>FX6>`X+>>H:GF.9BC_GMGW%_C%$19$L]<+^%Y-,']_[$J<23:O1R%=6 M[@F]\Y`7J0+3M.WT._0SD&_=X/)E[G&JUU4S?8O_"1<;O81"D2JH`^/TUIU3 M*`3^=,C">0>_ZYU^59V74+@.,H=\\A"\%GRA`X=A&>>@QZ]A43[KA<&CZS#G M9OF)X\O5?:="3\]>]IL3U4A_?^9TG&6*H]2`K$!QR`#O9''D9"][9Y5FVYIR M5!XY0,N41WEO7&R[G@[&+BR.Y!C"J>+(R5ZN>>B6I=O&47'DX"Q3'.6MH5JJ M91_O/$X1Q^:@RHKQYDFY:Q^ZJ=2-K(XW4,['7>8EOXJE7PIW>3YE&'C?P,5P MEWA$IZZD%V4.X0[\8.4#,D_ZC=/>U'+MO@JQ;UH-^U!=CEIYKF$;IE8FM1(# M%O#Z]*'9$KB5=V['M)274-O,8-)K##G/B]_%H:8/8^8@>!WT0G=D*-9+H2<; M*GLT%*LI'N7I?M^"U.7Y%JIEW;(S,D MO&@%YE2V51R3$N^+L&U5-0ID4MZ]"JIB&_8Y3,(I]9-+OVX#GP>>Z]#DNN5> MR#@XEOC9G21+:]037R/$=Z'\SN5C+^!QR/!ED#OUQ88'/TJ.-$*S8EL!N&EV M[TS9C7[;D_/*/3D\"@-_BK\ZS>&G?HMT[TFWU^HWA^UN9T":G3LR^/0`)3]C MRJ#]H=.^;]\V.T/2O+WM?NH,VYT/I-<%Z:PV]&QJ/'E7#YTOWOHCOCAK'Y#8 M.#3\J47R@+]@:]'9(/IL$0;5!^:0P9+C+257!'SQFGR/.WWP^VX+ZB\K/X`; M<[!E2)U3/Y[0<00&#K]P?]"1WQ[`U(1>KMI#MH#5%FOWQJT.D.AM3*4AN0I]"=" M.?A%Q-BGL>/BMJW)JD>"LJLNB5".^\.:\33F$='5*X+=!YG11T9&C/D@-+:@ M(=Y#[(MZ0P?/=I`G-YH14`+TT1YH#E+8`MN@ZZX,]0JM+3Q<8=TMBZ=$PG@L MMYA%P4I9J.I!]==KTA3YH1YO>87Z6Q(G$-O4DOUM!-I%Y&@O8"1!.)>%T4"< M=3_+H=X_8C>4F];RP>6P`+Q8[R=?R$UTX%),8'E@9\G^MCE>[\]28EVD!H`" MC:PMT04+UQ>[ZZ00$G\4U?U=;[SEZ(YT*M0L))BO?QQ,<&<@BI,ZO\5RKQ`G MWT,"=\4;!VS!1P%[($T,6?$9Q6/*,';_0'R&-[RB9X,:$Q&0"75#D&@^L)3$ M`CDZ[#%#5"96`97&7B2R!.MKE43JF/(9F7C!T[KSB&8A8]4YT)J)'-Q])O+7 M0GQPFA/F.Z#5O+8P?"E0<<.]5#+@)5R>17\,-L$O0Z-_K-2!':KK.Z);!&=. MK&35/*AJQ`A[7L@=G:OV)S&8P9+14/2BN%:%F[;=>;[M\%D0>PY6%#(JO`:, MYK?8E[L^A9OOM3O$[0=)YQPRP).UXV3X6%EPRGK0NV/.5\X.6;PE6"J6W[0$ M0!QWW2'D"SWI2=;NOFNH3=\'&R`Z6L-J8\KM.2) MZT':FO\`G4:^:D(PK>?QC/I3T=[F743;%-F8L/X\JMQG3SI6RP#!>_<8Q_ ML.0\L1BV1'[1#:]ND":/^)U7,(F(?*=H%Z>'30,3UK<&P_=`G!]>D3X M?>5#L]F#R4,2GZ6C%=33G/X.PQ.$'W,1>XF._O_:.];>Q''@7T&G_=C=YOU8 MG2K1PJVJVUMZ97OW.24&(@%!"?2V__YFG)<3DI!`;!J)#ZNE?F5F['G9GC%( M@?4V-AB7P./.?`YS%WL,-!$1SB#P8B;29ZF+7FG_;MR\O4R5$MJ?NSTU>"+- M,:.:SO7@D[!RP.F&X?V0`?'+X'&-WP9WGH$[,59?][M40:^\-34K=SXJBY!@ MR1LZ3"AE8B-V!18-VLI0FC+-30(KM;M$:(GIR_UT_/<+++[!&.7%%/X;?G\1 MZLLDYL`2)#Z)*`2T`Q$1PL+!Q4+>Z#R"Y>3O%\O!9+;S7V&.9#U1R)F4W\3" MI-(HH1*$:AM7C!8>8\TW=JL!^/W'Z$1MW!J2OS*>Y4J5]K!&2`O!?B!J#K1F'6.120(`!(1\_A]/)R.1X/AX_/#\_"/GZ)98X61 M^2C)!N!TS0)GOHLDE).V2'++9I.&?IKGHJ*C!@X=8K!UWF.AN%B`/TXYC;+$ M)_U&-?4R%^NX6P(_/LG2C:E+:?]&3DV^3([@!+ML`7.\B@%V`,QH^5+Q\&M+ M/?W$:TRP!]\@/F@!O832-?HX[I5&CB&8&U[D@V$C=$MC0G04JB9ZT[BP3XX. M5NG#J*4U_`,:-(6]C%0*Q/D8<`UL4`PV+J`I!O@<>?8:>7J^D2%2T4#P*5_N MRGT=7%VC*.SX[V(H"LP7(('`O0R.XN[&GH5CDKSN`?YY^1>\:^KYWV=2-$LN M(%4.2K".A''"971[(<,R5RQ8)\!J M+9HM.7#.P4+DLTY:<89JL'B*3?F?_G!&=YJ>`MR@W;T_K="(!E4!I=MUPG'- MFPN^PJ^8!IN4N#F<(LDA;!$48J8ZH\9SO"\/X@VZ1_O+))S,1X2>5);3Y$@G MP4RN6#5T.0+JI:C3MTR6^22(K)E56L/?#-$ME?5(2Z$X'P6NMH9EV9+2$@5_ M1HA+WUUZ#,,]3M5DCJ>J_H;F=XC1.=*JC#\_?&;Q+G$7I[H566>MJZ/@5>,\ M=5;0M)C$\@#I\F:BXX>D*J3+P>.)=?\D;84B3_(MU37@+G-_-Q6`M,U M7ER#&&S+UD["ZYDD>^>3^4$2CJI*T5MC,J,JJV#J"BUAPM76C'.P8F)3WD?D M=7>`6;&!X.QLDFI7S%H1L*YQ%/B<@L)FG&^#8TB<8+8$SAR1-[+R*6^RX::U M+00'_YL2FW:[%K+NT11VQF#;AGTI+`4^D*:KMG0Q-`4^;VC8QHEHXI4VXHZ= M8.-M%N%P-MNO:50"=`5?V$N$T+%F_`,U;3UWG'(<))Z8(/^&[MK;>.$NH%$&K/ANUE0LIQB&JK'!VO))C,:6TXS((]*+FZ'I42IZ'I9";$K#.= MZ/@'N3X-/;?/USD:36@_V<;7"A\W,Q@/)@ZW;,(H17X-=6O[76/0NW@7XAIR MU9.0JQ,O^9[`6`6.+L^D?H$$\:IMRZ;,W-@ZEBV]'>@\?3M5UR63/0)O#_H] MF?L!^8GOW>V#]^PPK5%+_FZZ:IM:_=R4@,4?9ZZ3:MC*D4D]CG,:,32F`4,1 M!Y8]C]2HY54G=J$3KP%FYZ!UJJ)JLK[SS,,^1L]>%2DI%Y#P49/8FW`E,)P' M/$])9ELY'^$X[*Q`BQR""/;#\LX)7^;E*(J9]W)*`#D/@RZISP&#?ZA9>H`` M+>9_S4M3JD&G()P#.=^7,-I!_A*2R7RTP]RB-)/5DOZ-QZ4EP6LL^?$\?RM0/ M^*>Z;*M,QLZ6(%^&1MR.)TII9-B&:;,AFGV@$;_SB_)UI"FRPKXFT`L:<3O? M*%]'%KY.RGD='?2Z=T)O5D>A\AX7D46:DM[:^?4:K+RO^*7(_XF_1"O3ZC7UH\A=]%=TH/'[ M;;Z.CG:;#5WBU4G)Q_"NF>-=\[,J MT=6I%3W9')GQU"D^]&!*:>X??&,B&(08@D%R01HAF7U9^&^W#X]__G8'CKMD M2IJ&`0'%S@74[$;FA1])'8;5TC?*`AR=Y>AD@X>UW1(JNH3B-Z1 M*K>J>)"J\E)@_TAEE0_TB%J'`C%:L+U'Z32N;,@#*="HN22ND]J1"5 M,T@5E<"/_P%02P,$%`````@`(W%G0>N\NV!P"P``!(\``!4`'`!R97!R+3(P M,3(P.#,Q7V-A;"YX;6Q55`D``]&QFE#1L9I0=7@+``$$)0X```0Y`0``Y5U; M<^(Z$G[?JOT/7L[+G@?`YL[49,^2A,RAB@E4(+OG;4NQ!5$=8S&22<+^^FWY M0DPP6&:08]4^S!",[.[^OI;4:EW\];>WE6N\8,8)]:XJ5LVL&-BSJ4.\Y57E M<58=S&Y&HXK!?>0YR*4>OJIXM/+;/_[ZEZ]_JU:GS3^N'\;5:O0U>H[1JEDU MJV/LKC_[_OI+O?[Z^EI;-]^>F%NSZ6KWZYI19V-CQX`[&Z;5J%IFM=$V_FET MOEA]8_H]+.@2[\\OXK\GQ+$!6GO\"\-K=E5)/)VM^`H[Q$9N^%"?"TEU\52S MU[0JT7U"!OCCKJ@0N2?CM1F4M?K]?CWX-2YZ4#+YW&8] MUGWW9$[2G@MEK?H?W\,$')&7?R`%X;X?'P8R<`MBM9OJ;U98<\?>,[0\XF_ M'7D+RE:!XF!,\.QGAA=7%<%B-:9(B/\EN.(@3.*"_G8-CL?):NT"$O4+J'>- M7`'K[!ECGTOI`S@]%Z3/%#%`[AG[HJRL+&5EZ9`%W M0GVQ;;J!"N,MI]0E-L%RWNE1SI%"@$?>"Z!+V59*&P*EU>DR9110]+>B:?FQ M(6O!NY1::X9_J%/K`;O@A`Y47G\[9\CCR`Z(EE*-K7VF3K4Q]99SS%:W^$D. M*==WGE365FK_.5G+HP.-AZU0'>3B,89N\`G9?R:8B^JJMPQ^E%/4]:E;RE;D M%ON(N)*-";35W"FE&<&G7"/D(3!#HDD$%>V-&^@QAN]Q>>*[<(-I-HRJL>M> MX._KP7AP?S,T9K\/A_-9_'AAU\\%'Z&"^,W'GH.C$"Q6T:5V5,I%3]B]JL"% M_XP)>B(N\0&5FPT3$4.M8_8:-:M5Z^P#E(QS%X@_!5'@AE>7"*U%<&S5L>OS M^(J`TJJ:5A0,_A)=3I&WK[HKPE+*8G!/ZGY/?>`2;=&3BV/E>]UV1YGR*0*E MM$\XQX#%ABP87\5D^>S'W]:,4`8A-+ACQ=APT)8& MC>=[<(B8?>"!^_%^5*+.1343-UGMIJ]OJ6,\G2A1;,K87I$9$L/(MD&.RD` M@&>:+95C"M!WJ'?-UFEN-AC()0^ZI9^^&95:O M"+[>17X&<^D&ZUG%1`))9!6?J0OJ`0D==\YDE_<*42EJ8PG/2&32J MFBG66HVV0D++1F$&`#I5U&C^(9D3$;DOA94S1>*%V3S57^QJ88;A&E7'X_FL M/2#:_4](]BGK1V4XS@N,1@F^M+`\811$YE:[T.')IQ*=`PV-C MT^RJ:Z>SI'\"S7D`T:@/'G".$X-JRVRIRQ#MR3I_EO`6KRF'2O9!]6:KKZZ3 M295Y"2_,PO_=_;*,UBAHB*=)'K"-R8OH(>^Q']O4ZC643BT#?(,:VQ%O^"[D;7&NW^NKF\*14*)+?W)AH M-(T78@#&-_OJHNU0R.4H2U%WU^\=Y52C\"5>:3QU4;B3(5YN+/J%?J>ELBT] M+KD0_F1-URAN"<;OH>%[P_9&4]UP(E5F(01F6ZM1-#/R?.0M"43/D478'[[9 M[D;L4_M&J?-*7+?6[5I-A:%HM@:7X%762=]#U7S(:-3Z[H^$DPF85J.H!,!E M*VU>G+XU-]6K:ZD.!A1.:87-JUULM)WV[&0^Z$N/JX'&1_9V&PB3R<;F% MLRD'06I+7%)2P9(5]1+>V19[IY1E$CY(4T.@7&>R2R:<0$"CQG7@."24/T7$ M&7DW:$U\Y":LJ[7ZEL*40J;\,I"=#R6-0JH'L:W3P\X0,0\B?CZP[&[_`[6UH<=K+/Y8#[\/KR? MSXS)G3&9#A\&\]'D?F;\_?%^\'@[F@]O?XV5R;6O5?*.^HA/X;E@MV,PS??(;`\8B'V'8$ M.`;C/;@3H(7'+V&@CQGFX*@MLZ]N=;)"S2_1$&2XPGM6I!C\-0H4=J9&TV/7 MV(.63V0?.J9J=SJ06K@KG+9;I\@=O)+&!U.$MD6&B15-"AO&8V+/;R3OH`*2 MI1?.$=G),U.^06?0FV%*8W,VAR44\5Y["V(O/Q4JK!BIL8&,LNMVN MRI4E>\(^B=43)NO4)(GE,MP7@5]H=[AJIJ.N,4H1^&D,GC1=HP4GDWW+PTZU MIS`3GR+P_+Y$G.'$'_`+]C8!!Y;9;*F+:CY(N\C4D`S\N^F"$]9JU.+?4.Z+ M35%1+>,UJ]EHJ&/MH[C":3MIKTX-OC!DLA#3RWQ&7:?6[O=4)H_WA%V"-0G' M2W)VQ%2-:MH,!V/8;S#V8<@%RP?.BGB$^\)Y7W;=G&5V6NI2A7)*%,SO&X#IBT.TH7RV2J4##5N5$I9XR>`4BQ">;=FL+3T4XY.\12(BDU MU"Q71_.STU#MD]-0-X/9[\;=>/+ORTY#'3\,_)Q9*/&T*:,O!.ZXWCYR[(R\ M._`"SP8:!S8$#-&!&^V.NF&,O![G#ZBBL&E(,[]K4LY#3*8I*]AIBFF:R^+A#"[J-KD*?R)1? M&E_(A91&'>R!DS\`*(S8,$JX`5\/WFT"<>1D$6WO$JZN+NN>5YO2N,=/H*A3 M.'X$JUVJ;0\KA0V'O![G=YRE7LA[GD]+\;3+^AVSOYR9T__W68=+4'[N=$1) MDK[9!RJ(U#>`%/IUK:=R='@HKRPLGT9"I]V>H+W84X-OGFI/XY2ZAEDVK`?[WQ/S'X'YY6H/&A'0H?R.D(68*EO)M+&'3Z\]J[6 M[BI\N6.F^/)ZP0F<(@?H:1#?']IU_"UJT.0I?'UK'DW*ZQ5RZ$4.TM?200Y? MI"A\O\B(X5"#\CK$:;3BI)"II2<$0^+H_,^D@59;Y5TB"[#8'71(&J8?XCS%H*;ST7*1(E&UL550)``/1L9I0T;&:4'5X"P`!!"4.```$.0$``-Q=:V_C.);]OL#^ M!VYFL-,#.([DMVNF-.M*N::#22?9V#7HQF*Q4"PF$5J6/))1G^,[P.F`S5 MH3H#\?%7WS]\N+KZ_OW[\#!^>W*MX<[9QV7JG(YFH+_ M`K,/ZA(\_!086J;]ZP?\OR?=@P"AMKT/+CRX'R]25W?WWAX:YDZW@HOZ'O9T MA:^J+,;J15@.0S#\N"1!Y+@OR$Z97@4G8U/L,N/C^YC8JLOE\HJ`C?`;X[Z^/-RRW&YM>?79VQSVT M_95MK&W?]-]O[&?'W1/@*!AR[5<7/G^\P+5X&541=O\'MJ]N> MOB,5S03-/?@N/VBWCOVRA>[^,WQBNU.6;SSQ;*W.[M?[`_O=0>*QXPA'M^`M M1(_!)WWW:ZKFPK9JOY"3;$`MW[&D5)'/T-=-BU%,D%9[AI1AD+_91,C641@= M)/%9]YY(OG3T+E]T_1!@M_0G:%WI;R:ZH\_ZT0N.\`MHZO6_U"+UZR;]!WL.>[G;]@[W<9 MNEYC(:FYRX5+EH,F#X];]"NR-'T+F9+20%%4<`FB#G_ZIVX;(.C]`TKW'V/L M=3PAP`_??&@;,!S%B"-P=J$5B>7C!3KP?RMT10-?]8NEOPS5Z6*Q'*KJ<%;^ M;/3@;OCB?$,:;0:/1?0C_S!$A[)7SN*S\/"-XT8W.'.+5VZ$\MEU]FP@?0?9 MZ4\YN\4%<%P#NA\OU`MP0%+@HGOV\4*Y`$HNHO4'?10P(_D%'E+!6E)P:5.>E&I@;0 M(UZ5%ADI4G.L$C=OOE4YU\*3(#@+\&DDDP;`!LV86*6*JR?/=U%/=C@>JY,) MA97T?A/3-;N1L"7JB)!,Q4>+V40924W01G'P)FP3,%K-`Q[\3U3B?WG265V< M)9\3V$T(K2[0W5_,E=G94SH5"3NIC?#"E'RO)W(GL!)ZK^KH/6S'[T#X@Q[: M%W3,PX_?Z;BGS*'42S\L9P&?9S:ES&A\%DPN02Y*CNGN$X:&*41@`(A%%TKB M5"2ITQ$70L8^^J1C%7`Z&5,E1N>1)U!QBR5BUGF!AB23[4#">,@M[I+,>J9@ MQD,_!*P#G:=?UGXL=R>J'+0HXA4\)ZP+5:];UVF+`!'1F/=,-7SA?AA6`C%/ M+&(V/@\MB[&*HE'D,&$//M*,,D$J>(T*N[IU8QOP[1_P'5?,N*_4C>JA&XE8 M04=L*K%75*EY58&:-\/*76MAWR$\!\A)@,ZVHIVSWSLV63JQ>=41KONC3Y9E MFO8+J72^$;!9.CIV5A97I.5"U-@1!O*W#$9.8&`)B.0"!+4@9M^'T M%]."[C5Z=+\X;J!)?8V>4Z[?!VOK`&=IFK5>RCTE4P99#`T+?B/:D1,@.M.& M9(_PQ<3#-;9_I^])'C7NJV-+<]`'S6HA9WF6-U?D[E.4@Q;#-8KGB&W)*8#/ M%>B6/G"+?K%/D8_`)8A7*:/?GU:WJ[OK-=C\N%YO-ZVFQ*EKV)O/@0=K[+P' M_5U_LF`X-S54QXNE6M-,JA>*X2/Y1A,>+G':<9Z<-9!XPKRDP&BRF$C=@*J! M'H`0H-FTEU7F?/?"ROG;*RID,:+-L_=+3IKG?BC*%E.>I]12H[GV3O/X(\C=3"9SLA2DS^J\\%<71#C MU?'EZ/E@K`[(6\/D_!?XY!YU]QV,EL'1`?+H'>#.-[]!JV'O$8%VC]"X-?4G MTS)]$WK)PWNIIDP\Y-[3)@!O2@YK\$1LQ:^':#MP88S_2O#,(,[_:";QHU] MK1],7[=2H]##R5*MF\KHP-A:_QVIVR*^F,(,917)>X",(7#77C8<6F('L"$P M;1":#C(3'MQ(SD>6Y2%Y4:=KRP92,Y%[H6N3,,0H-SN@-.L/R/@R87U#GGL> M]#U4S>,E1\4F3CH2M@QHS,K`8#&?2I[4IG%R%]&4,RWX1S=^J--S(4B"-,<0 MW(1&DH\.9)$V4)^2UV[9J1+ZU+;WV]4M6&TVZ^VF#662%TZF:MV*@*[$Z><5 MD#K<61K%=LO)?'X&9,KA%2,\6:>A`+5^M:BD@OCD7_R)5I;:Z]8\0"%JDSJ5I=T)58_8RPUL+.\BNP6RO@<$J0L7#%RE?$9JE7; MX3QZW?!,GWARJBR9BF>[<-8@]]M@=,`"4ZN<:XULD1*Q"[1/SL,KQ$J(MS45 M(U]]/AYKHZ`2+S9'3?83);^.*1.$;EQM&66\)PQ3<565?#BM21B\=;8!%@T;D04/Y$?* M?`!T'T0E`"G"D_U4FZTX4J/I6.ZWYIH%(D39&T%*&L(._X!)@8:L M3V9)PJK'.\APD_>TS9OJ4XD?R>I!#%W*::ZU;)OP)$S`W#C>4=H M]$0W/GHJAFY%E0'Y_J@,%14<=!=\"V@X50:* M0OX`+W@U4S_ZK^C>_@8-(I#CQ6`YG@UFLWGPS_E@,E?)/T-[DQ#Y+X`8J8GA M=*`N9VE#)WGG$V<;+=9A-MTU"3Y#E.@;Z!;@)4=D#R;\;/#?A[,1Q]'6.(]'LK+X/LK=9NJQ,YO766=]][(RQ@;A<'TDDMU M)O,8(!$IP!8PLBS.O(B6FG'C-6X]/R>LJ9::75!?SQ7@I]T0T>Q"B5;H: M3L)R'['<"FT;]^T.CF?Z7FZ9RWC"<Q98Z&3,U4"-7RY5SC6(!>KEWGW1<5LGYO65*D`V11& MSQKM3-]EW*65/?6LP7X"!2VBT#80'<%;";92S_7^8#GO$(;?DJ;O@##BM_*L MUG\WQK8)+][JLK[L:+*4>WB+.0;>>'.3@_Z.O%ID,4/$?%]_:[K;R8WM(T#FDP7C0>3U MV\XZXK43?W<.M.>B\9+1OB#T+*4#51K)K?7-`A$B]XT@:0](V\G" M>1M1WWG&6P\>]\=`\?6]X_KF;\%*"KP5H:HL!XOQ(MR+4)D/9A.EY1JXIBWJ M&T+IN.\HF.%\J=9]%JM+RTD\=6TA59B3EI"RFB@CNI18?(H+= M`Y,X:3!7)E$T-65%FK?X$XK/3`5<&%3+5L="M]\*ERPMEQF]E59WWWLC'&!N%D/22D]%$[GXV M8P0"U:\"1EH228^@S?L$S+7-73)/2>5*<:47Q4HRE?OM6^881,MP)9IP<[_; MF]6GF]N;[W_]CQ_O;S^O'S=_`NO__GJS_:5?JB<[:BA3?@.F MK"CX,K\\5M8&$%\!:=%Y-X-<)*<6]RR<$I%OO1-.8V)PZ;I+V@@*77[F*Y#Y M';F'`QK'(F2HH"DJC>MS(7[]15GP>^VW[PEA%OP40L>SQ8N1W.ML2S$+5.J, MX[0FMURC4%%GW!-MWJ2K3*;3:T(EW^JS`K7HA#GG/[<[8Q_#&/FMSB8+(>,7 MO>Z/UR"< M=U8\V[Z.4%V%W%--,4RL3#AS2^C/9P*"`EQTVEF$$&:>]_XK='O).Q,72>XP MXK@K0:5K#B0MCZJ2JW&QJ:K(O14,"_R3R&@60YF<]I&.5M0V[Y3T-!RNRDPI MQ4A:=@O^,O9N,/L7$47HK' MCEQEBB&F*,UZJLXE'X,J1\U=5$M=:^00"(]U2$ZK*I"/ M,D40T9)FC%JZW#LIEX/FK8REGO/"V&IJJ*KFN(BB4.X5))%F3)(]B:%X0NN#[I+1D\MW?/,9Q,:Z1>/Q6AD#9+^^-L\9!JQ:Z\R72[. MA^^,T8B4839(>7T.2X&P6`^"S4P7[DHN7PNIE/ZZJQ!IDWL^MDTXPA\5C,#" MEA(]0WPGWJ7@$)3D]UC)#/!/^6WIQ8*`5RNIBK&^=62FBA9RS_HVB.)TSXL\ ME-KG1-L1CT:,$/R(.`GK&SP3\I-1OP/>1W&<^"E01,0B_]U'6<@L8F&C,W4T M&O-3?:K/;H1G#2.B>(F],I[*/>!2B9NW>%W:D&KB0U1*5$#*K)=I\0YUZ]60N<*SPFZ^K=,V!H.515=(T^6#X M4O)/C[#`/XF*9C&4BFGKE1)LU*LOW7,/M&4.*8MOA6^M?`<"$^VS("KZY"+O`IG8D%+Z>:D)RSW M=%DU<"'*60DA)B4,3C<V^:P1]?'&^0N9Q.>ZECN MN2LUF\24,+2BU&P\D_LU(0;T_)6S#H(6F0P`,8JW#2-F+;;T9JII3HIZ4O92 M]+6B%)$*N4?"F/`+4MMZ)-K#X_W#^G'["_A/?7_X"]G7"YL[$/3YUSF][\7H`W0C=*L"(UPR%YXKDFY0S MQ\!;H5F!:)$AB"S!#RE;$!HW_#9.$QYPT6R9B%X0\/K"P9=;)G)_J[))&$+D MO`&@A/8P-&Y&\(V/KHJ?%/?/7TQ;MW>F;CW@+V&B"DDF_Q1^2\A8`'2C>*L0 M(XJS%<;C0'+G*HWBX*WI3A[ M^W6F`!+:%HV5Q5AN'2X'S9^0)9ZU])D_1=M%KWS?-9^.?K2<]T%O/J)659U\ M%D>*)&1Q6639%O5ROZI?@;I!)M!^062Y_W`U)(V?78F8[%"S'/%\\//9I[Q) M/.7DC,O,%XKY:XV< MZKA?5F7M<X0&\/4W8(4;L#8< MEIP_< MHE_!P>RQ*"S3Q_>#A`I0;8!+$,_"H=^Y2;8?'E;XDRT_KK4W?O M[:%A[G3KX#K&<>=[PYVS#V[N)QW=MAW\'HWBOTL6WV5L,W']H&-"[J MFV9F'OS@PIVI8Q*BWQ8DVL=KCA?:_D>.EJZ+P-X'X?3NF+Y3=1(#?O8J$ MHSBDH.3_WRT4!#.T?:]1[B#YK?,UN"*RJ\3V`A*QZ;:+>JX/3:[C.0OZ+>(AOOC MM#$D+2X"GAT71(5`5`HDQ5H.TK7C#I_GGNPMIO@$:W09(H*_IT83!23F6=0& MFA8W%#?54/1,HS*B1J6'MLT:T+6SWSLVZ9>CGNF]2[K"!NG$/T!W@[OG>%!] MJG![TC`@Z-9:VH48-1*FTLIL+O<@>8,H>#]&V*%H@6DT:H2LT2T.!FN,8#P3 MH!*`%.'(>BY/"[E87W@TL)0F(B7WIG)-PA#R&&@`*,?^`V+_-\)YU$D)QDU; MZ-X?4049A<*J9.EW-L9U(,7J-YT!#G: M!D8@L>J?M+SU63QIJ^2X4(C(A=S#QBSP1^-YQZ"F^;U/ M4.*T9]Z615+*V;"`JHS'D($A*QI\N22\$2I<6UJBX/#'.J%$5GBXMKD644NZ4 MJ4-40IY$[?%I#^B,C=M2>MV,WKHM918@!T]%,K>ABGE'(O#8XTKUTA"H*]4C M:V6V.*/7)+*H>3\+RET77I0(SO9(0#[OB@DE8/%=,8HU:MQ3V=\5JX`M1#,K M`!2(Z-&)V/Y5ATGN58?-=K5=X_6+&W#_!>"EC:OMS?W=!OSP]6[U]?/-=OVY MW0L/L1/O_OG^`%TBZ=Y76S\:Z(F1&^MK\-;#M>/Y]\]_=QS#VSB6,9PN%_PD M/N>L:Z^Y!GG24.&=A_)D._HN`'K8CD=<%V%D MW76G6PWX-.&RINI"\L__ED$6(6H4OX1K7O#B4*NO1)37%I_-9$1QK;A%3,&6 MY%9R+UHNQ=Q`W]IO^E+F/=S=I6_JQ1N(C2_J.Z[,9,QB@B6M+-546= MR:V;E;AYBV:5FP8R4F4MA1. MN?:2##8LU#J!;4H3<2)]Z@;!)N2T>EO,%^.EW,-4C6,YG=Q7H-+N_K^]:^MM M',?2?X78IRH@G?']L@\"E$2I-C:Q/;;3O8UY4FPYT8XM9R2YNC*_?DGJ;HD2 M28D473W`8#IE\_(=^3LWBCPT-F`VOU\\&V!IK,#Z5WUEU.-_.-7M:-P7MZ!* MF+19?A,E(?$YZM!3_4UL.7#9YCLS>Z&U#ELT2TPIAE@*,2L-;=0!QWUJGU:K M@MZ*&;T`H7'Q\?'D6O:;$U29V'YN7-/QH"V&#_N;:3M/)\\+*WZ;/VZ[O9'` M\D(,2&IN,ZPECA89ZA`2Z/SF^[9RATTJV?`73!^UPF73C!XS^X4]M.Z;[.?.MHS>' MOQ#L"1\%'/YMYL#'87DH<>Y,Q07O`I'7TS^YCS325Z&S]H9CM;M/L4 M+X(6=(TL!V(L2.8!R421MPW;X[EN0&8V@*>[`=D)032C@D9(S#Z9O[85RN_> M$3DMWM:B]GJ>#/&E["F2(`A>-5RN%H^S#;@S'AKQVN3 MTXZX%T>$.9M0V&I!LIJ6;X]W+*@=C%=!E^-JB?-K-(J(CI9SLS9!61I1LJ0MZ-&93-1><*E`+H>RI.FU)%*+]M*!+V&3KPW3 M4\RM0>WP,W]_$*'+.,B]U3[$7XF=@J1-W"54A4-;NJ?OMH?6^%#UXW26P5>[N5646.LQ&KO M:BB#+>5E50F`Q/BA[9`+_]V*(CLV)L(AD[6GV\FHUQ&W>)N9JQ[]JF!'S,NV MPRMA:G.N&+"4-'P4\I1_ZUIRB8;Q7OCGGP+V\Q[&0[I*HF<=!U-)FI?&THM0VLV M^`)(N3'F?FU#3P,A^9(R),_E4M5=<8:@]J4\]$)(R;.HX6B+(OOM,1KP17:N M((6!.8PPDUTP83W^4DD0,;:H\;#?4WN'&QFT:,-+G%E;Y,PLWEG6'/G$A+I2 MV9T7;'90O(`7I012K#`=EBRC=TE#-B:OS8/EK6!OYXS?S78[_8&X/<47L]5C M:S7TB)^7+<>]@=K10#%@T7:T<%8M_(!CBPCQ!Q)B%^5P*V?[+EMB]50[+R=! MEF+=")/CHSUK_8GU,,_:PB>%OL&@U#4/T&3JNZ/MV&C-TX>A:NR[.J.!N*2< M#D1-1O(*&A.5;H#Q8*)VQ,DDAW"3R0!&"QO?@+`Y]MS9#GSA*"LWQ-A?!94@ M;ZWI!L!&2>V5+$9)Y-AV)DR)/KRE],',=&'3@]\M^^T=E9O[#H=[L^;GXZOE M+O9AU:2"ZW^[O;ZX,Y^,:.II1GW1(Q5A'6G25_Q&13Z!1'L.+E1:U`N$W4#0 M#ZW&!5W2UU9SUJ_CII(0MW(=6I1S-,PC3<:304?M+0_<,DEQ/KSH^(KJ$6;+ M31/6O>[V!N+V1C!A$:(@U&)7J`=A'&C[U#[DPR-.2PZF#!.K>^$HX\Y)()FN M12&]H74KI'&PB5-[EQ*G1&VZE`IL/+<;T,X4^JH'V]L>3M[9M7#5G.2^GV%? MW,O39C#*T2/6Y\2J7Q7C=T<]Q3?"-"NH*KZ,"BV;EP,K"SUP^V#C(E;+Y>3$/[IY8@\7+9KW1YP^S^;<&;U\?EMZ^?J^O?P6/3XO?F[U] M_=[TWA\/IS\;N'Q=W_W?.3B_[6U.D2FT,N=L-R\^WSQK-W,B??6 MZEO?_F[[=OI:PO%8W+*K",3U3)J<9Q@9."&S=8=CQ3>;BQ1;='@C$+N6&AOX MISB:L4!R*CXJ[PN_1I.`:!;P^@G-$IP(V,[7U&;Y9#+N:$BH2@B)C?YB9B47 M-PF9#;T)G*B=*`F56TI$)5*"2_/BQN;%@>;%#LP+_!S]:XML"RXAGAQP,..1 M_YOQ^F8XF.[LT'^,?YWM[^8!0=#]>]-U/^'(OYF',SI8,0TJ!HBY<)P&0ST= MYQ4SON>9JC\Z$]51.Y=A$X1>KR`3[=,.!L^NSZ==3,`T'/"C2Z'Q'\;?7V:_ MS9Y0-G`#[HQOL_D<9A\H,5@:J]GB0:A*B+G?7#F5R%]]3OV#==5>.6<3A%4E M#(>SUB$3K#*%,."GC:K"$@L&O9YKF9[U8`7_1:6WQ%UYQH)$A%[0RERN'811 M!E/%R\9S2",ZUV.'I.&D#.V-PW^D>MV`H!^(.H(O45?&(_5Q9I]-6NUJC=SM M3A0_E=B4B#)\6@,X`T>'!@IN"4/_BL?"#C`>+;T&F8S'O1S9&$N%)54_@087 M9F*U1NY-)N..^A%H(S)*62IL"BVJJ!=$JWJ=!;ZE:>\>SBZ<]`_+=!]/;L*I M?G=0M-/)M3Y:_.1^.#U6^U@%G0`R7$\EBL"Q MH&8@:`=00P!;@JBI$')V)U?"S@0H%3V[D^#)JGV(GE8$>HKN3MLS>M6!=X(U M2]4$3PE9D_#F5@A?QU="U\)(@MAO'#Q9M5\S4DH@+0JHQA+P]`/Q=!?PU'^W M0+!XC&[I8O7W)QALN.B*K\5^[9^V_]2/I[/CSSSO;.W0LDNO)^X`?_GD-3G- M*EA,ZHJ.@_%`[2TY=`((CQ!H4&A)*[P-&+6[`4%+$#050VU=@'!@>V@+5^GXQ%^C3]AX_A#.!H<`1WL MQU'1_3Z6A(GYV1QJE'5`9T$46)7;K37J>G^'6SU>!%6]I*!%K4`J2; M`-2F:>;1A;)M,2]G'"L>G=I[/)]>U_X\]ON_WA2-R!4!H( M=9G,)61":IKNO7Y?[7<(+&*(]_'46+1TVQL0MP[*GJ7:BR2^D/Q*->(7A!/5 MW<-*LJI;=A9!)(49#)`R.A#4-^,FOO%C:WG>QOQQ9SG6WO8?(5OPL<@[T\MZ MG()W=;?=SE3@5?>UL-53E:8?2Z1#=SU=.E M:NC)Y?79EN.IXA7*BP&+=C:%LVKA&6G\,7XMWQ#!A)AV.03+F=_+EO@5\751 M+((LQ402)M?P)\S\RNQ[GSGZ=HM>!<&1/\W7@W4['/?$!?Z5T]>F(*MT*4Y6 M=.WV%5]8IQ5!@F&DP:$5'$,"M@.BQB!L+8K@HBRJ&@0O,KKE78-5B*G:VT@9 MI)!EFBGQI.B^2]/=C.C^T2S=5];6LK\'G!CUQ6V&HD$@BO1E,E;S/M6[.QKT MK]6XY\5HS\#GL%0:^:2'0.(/_@K,'_!1'YLGM4L7,,E!0?YI0'['>C-]B[-N M`0LF[4O4^BN(;'_&]+M-*H%[AC+9YJM]")9(8$0@=(FB$H$`':B4L50%+GMW M^U.UMQ(R2-&*[2^$4F+Z47N0ZB"0]?*B_/983Q?K7_0.`U.USSFP"=)>Q$^" M5!+T8QVP>.YO(R((5XC"''LP%'@$@@J#(!6H$+-2";+]>^/Q%4;^)#E:,_\% M8*H<0+1&WE3:2^:&7"?0F@K0^X%,?VRKU-[8PR9(NWZ@"%*B"BGCCUY6'D*G M\5F7_]%&T=2[`JB&O;ZX6F54&)KF/YV89/X7]A]WKF[5LT0.^2Z`#(;D`N)M MS>G7I4)50-824-LZ0+,*5##`8!28*N7?PC*)TMI:4"DL+6J'-&$7:0+R!J;G M68P;^_-S&\>/P^G3LE;6`8N43AA'0YGO=LE(FE8)%IG)>E$R2K<_4'O'%X5#WHQEIAIY!$WK"(V,9-THZ-T=#4;7 MMM)$%D.^\R!B(7F-J$.TQ'2#+K$12'U);J)5ZE.XA8+>V$C]!-R/Y&C)#9`1 M:5GF1P[`#CO4)_UWRX&<"@*$<5&Q#G%LCZ=NGN8E4I7Q.^G6[2M>$Y@&?ANF M_`(#V83'#45P6-:BD&02TZP!I?MA(W)M.R"*!&AMO:<`3'K3#V2R';:HO=`? M7[-U;W[8OGE(ZAV.9&[S(<%HFM_4XI*I3ARB.QKVKHWV5<+(-^85B$BF/;D@ M,NS'78Z=G322(G55=(0B:"<.@6_NN[;0O5*:E@+X*ES:_3LZF.HA_4C=>HC> M"GAX%>>0K/PP%DPM`.._6^[]V76A7\JLQ`[[`ZF>I!A'XTI"+6Z)EI#&&$RN M;FFG0I86_$@I(*(;0;U`V*W)]P*5?)'E1!11#QHG0A@#1\37EB=7"=.6"RF' ME7D/X%G;,WK*8&=]G#R;H]C!Q>1+UT(5O(U@URK,-ZG:O\!!EL0CR?4`A#I+I#QL#HYE-U`0"R%HC:H7=-"M%V:[1-A:U:R`R2-': MFA$)469[T$?(<;'1>^51O?FKU<+7Z;/1@/X.X/J"]K^,=L#O5E-M?G][/Y-Z#?;V:_S38S M@_%2;7I,R>NIGL!"9^QX9*D/67YV+4J]ZIOT?Q:?GQ:_+X&CZO%LSA_E5RAG0EW MQ%W*0H]#B/I0R5NA-D5CP"A=[0/MS+*TY(6(@*J<3]RQZ12HC#)24R`5=(0Z M!2H:!%LWM0_\-$TC')6`%G(C0F8Y*?76\R M4?A5KB!0"*6.N[E`QN-WFDYZ:`@F,^E14<%HDYZRL;#I5'N#=@VIVDQZ*/#E MDAYA_BK>%9L)<,8=V7ZJ`(<0]:&2MT)MBL883#MJU_%EEJ4E+T0$5.5\DC,- M#2<]9921FO2HH"/424_1(-BZ_31J$DG39M)3@JOXO<]B::QT28XD'9=(WTA0 M@D>6TI#E9]>=3"1^EU78!_`DL3'?)I@FFB;+)8IA59TJ19 M4&-_V?AS-F;A@V=S^%"@50W&O9V(O",^/U\]CM'@CXA6 MT'8X&*J]UD_$+-JXD2;6@J.YX3>AK6N,"AHHG:R58J; M@GU-'*\JPZ#%U<:W8:61-]-VP"_@]6P?=BAC.J#C5FS47`9WB7N;D[[]U]EV M+1AIPMC2_UQ"?+[N[`SXZ0=J_0XZC&YCKP1P1G&&`U[:N\G999% MM!EF!:1%'5"H&78!49\;@'O=X*(C<4?A&B+&J"NL(GDG0#_(.%AE5?N\&H\X MDEP&![1$9_8G%S[LH#U6$JLA)5E9'LP"MU"J>SBVO;*-*.2Y'#PY:_^T_>?M=-@35P*ZD`I M@G`_0H=#B]H!]`."J"6B=M`6X,:B^"UDV5P9?N>6URN[HCAX,E;\&!J#%%*6 MX>GQ7+#=AHW1XM0V8+I7C^EK\P"GG3D^Q&B_'BP=%Q6%9!"XS[)Z_N:X3BM? M$=D)?4>]H=IOEZAED&G.RX!<,!PU1;8\:0R"UL)H+MRBMTSS4IM.Z(M7R=4^ M!L8@A72;7H[G8L4(!N8.*[U7UDY\[G5Y/F/$F35N/RPS"1!0F M=AE-!FH?#JE`+MHJET^O)5\C&XP;\%W&7OV;BEEB:8NA^3438A^\;JQV2EB) M7=(*2!6.Q)+"8-C!;/VHR];P/L6EZ?J?#]:KCW]C<=O$RZ9NCK040A7Q-M<- M6@FU:]I3H)=I8HLA7)C9Z`);W`J@9B+8*][>MD'?:CPMV!_ M25@R+W*0#8Y,,/IW=,/L!^S%?.YM_6ZZUIWI6;O[TQ&5.C;1#W,[FH[$[3`L MGK,>DVGEB!A,:-^;*+[T4(I;M-4MFUS#7_[RBKX%Z:\;Y:.0=806^)A;+RAN M'RY1JKU(4`5=RLI`!0@-K_B"@)U;?G;ZT-(B0[S8HT,NCX?3GZF#2-.NN!(O M93/79"J33#%?RWKA-1BUWU90X1=N3RE`:.N-OC&>C?EF#1:/('5&ZLO+7']Y MF&V,AZ_9_?Z?`/T^_O%RQR?YETNGF;W M,V--?)KNT3M:.WMK'C[*#XYGN[LUN?CT70_ M%_NU_>;@C5B.KV^WI[.#CAPO3P=[FRN88OWP+6=G[?Z+XCB4^V8Z]K_Q=/=P M1CC>+O@EG-T2_I[HP:-_+O9A45OS$+MV+WEJ"&@9O@V$='=`6T6Z@\Y47"PI M6YQZUDJ!AQ\?%),/I:_X?NFV'HGHL*0EN;3TO#<@,S,^[I">&ZUKQ[.#9/JT MH49]4@A``@%$&,`_$`J`83#&3.WIII#HZS^&D?'AMV88<>2C^.GFT!N+.!L/BWF58C(IUSC>+U1]<90N#/J]OL"; M*(D3US-S3!(EUPN2.V$FJ?V&G0:^Z`B(`H,6LYU[U:5@EI3#Z0RZ4AG;D&=F M%*J$M$FW<4_QFS4HT+=`V0L(6MPD;;;Y`V"Z7UK0C:WMTK?@2E=RM^`D=T_M M=^MT`D@)KZB@).:WP8BF?QG1+%C@4=X%3Y?2USQZP2IE#1%?-'[4T%]$*(=BK42+1B3>$.C8@3 M%YKE;F\B;@,M"Q1!O*<3NE('BH:9#`9J+[)R2-.:5A`A:1](CH]2UW`$@:,%D=&@@]4U(^>]V-^:RR)5OS M*WIB0JF]*8-:!M%>CA:(1M85[O"/-'>1D9A.Q_*9WK@CJR5Q%?^+!AF-I]>I M"&1AVM(((B(M>_(JW:>9F(^'-4(B/J7U)!?NL0R"K9S:]2YYQ)$2['$`*_$F M#<9[P\MX[VDQ__;+QE@]@P?CCF^![^GDO&TL]Y@_F<@0UZ'.Q>_ZQ!7@+)ZS MGIK2RA%I)*$])H7:ZQ,5R$7[I/+IM2RON>.Q["PI+]?MBRO*1YBT26*62%+, MS-1BPE3QFF3EP.7R\F)V#7W;3`14]7L*B79:868NBB%UP+JO=OV/*NA2HI,* M$!>VL\'H8W09?:PWB_O_`8LE_P(3/N*Y^*BWJ)1@PK4"XW.B81AW?_)\#Y\U MQ4=)HV/Y*><^%!BDU,)64S,;?BZQ`M<;%_-4[>-V#4DHW%DU`E/+J#%_K$4+ MYBX-)OV68S@2]^J_)CI)BDC]:)A5D3#RM#M4>X=:,P(JHXAE*+64;PV*-L?C MQ*60\$@W(%VW(RXS4R,8;8J?8J+6GT)U\V%PS9&Q]?ZYE3<244Y8W0S8K#=M M,/H>YZ)O_'$+ON#!X\3;JOL`:P@Q(ZO&WGLAQ/0F&4<8]Q6L+L@LC6B>8$6FX0'S<)?W2MID5 M2R[:B"FXHK2FY"NOT(\2'!/HJWWD@DL>*2$<#S(F-]-8.#?HB"G/`KX\6+YI M'[RO7!%?C4(MX;S-SL)OD3F#XX M[?<`=0)1+\$J( M=7P]V/C^VSWP8-OI9_\= M_O+_MG8P,AOWQ:T"-XZWYO*"A,=77JN^SESCD>*KV:)$%K[T)P8W\;('D!H: MO'X6O5P&>/P;$,R`;$@P!T@F4<9R2+QNXF>T')2W7-2:"WFESE_->,12RUD* M%89?"U7?C+_"UW7:X77-DNS`RO)\U\:KNTL+DF>W<"X1/YL_[./Y>#N83,=% M%UJ!5*?PT^1DUT( M)34G"^>69)[PITN(S%HX#Z9O+?;18\`C8/4J.M/6M$FJP-&2'6)_.K5M3]64 M`2?5WAPM7GAEDRM:"1K(J()O\%PHE4*S@<4>9.93S8H(SIVNW(HTER71T5#M M\J_BA5<['Z(5@R8)"B(-U:R!Z#SGRLU!@QD-'9?4/H4B7GCE63A*`=`1%?]\E16443G-(QX--P>9Q1Q#Q`T M!O\(_\M=+(25)W1Y@XH,S\7T##]#OZ.V1V8514J\S0A*N]/7LS5R)LN5L3;F M&^QIQ+*9,NY5D<[YF)3)K*A]J(-5%%GQ(B.NBT*A9F*^/P*SC=+#5VS=,U_? M@/3G'Q!8A/@&_3P[X)_0IQ\H,/3?+;"W'9A@VN8!>+`9CBD]\`4-;OTPCQ\' MF'J^K,$WRX'QT^'PB?P(_(G@.&F'XMIP"-C6NP%1O8TCG.0=1JSV=[SP%<#1 M4S!GCZOU5\85\OB$Z^53&T\'XFH5D&:MI[3TLN3N\ILELY,0%U'91 M.9FB0*%+GY.6#E:/>*PX,V59B?V"YZ?V-D=*"40;3CH86M`,Q/6):EM/RA^> M+J5LGZ`Y^TCS7-5>&:&40(JEI,.BX?*.#T"?K>Y7^F/^UIPF&$F9%K9/R7P2 M2/,4U=XD12F!K)2/#HZV@6E8/K]SP]L@8+YV"*RK&0[D,69-^37P`E*,BO(G M`GDK!ZQ'8!Z\$8>K^P8)MMKI$H,4H@,`>BA:T!0M-B>-ZT<"#&R@BP;486\N M*J!]V&H?'V200DIT0(]'V_QJ%+ZS%$99RG!!'<[FPP;:QZMVSL\@A:SP@1Y2 M=0B!EGJ=P#Z?]N`4C\@82BS<-],)-P[''9&(C8&LCZ!\RU_%:`-H MW956SQI2B=9%?FC$"IKHRH!@]YVS`_$``(_0V$NC6K236!135 MF/D)=2^22TK650>A9CPOGQ9_&$9X^[C^N[YZ8$S"UN=7S_K7&4YBH-=H'F&[ MQ;#;$W-L2:J_8K"1)D*0:0,+GVLL;K.\9Z,WO6-\8:S.8` MO8!XG,WU^?U,?X+1+_S\&1E!FD-:T4?P_U#Z"C_Y?U!+`P04````"``C<6=! M)0R*ZOX7``!"90$`%0`<`')E<'(M,C`Q,C`X,S%?<')E+GAM;%54"0`#T;&: M4-&QFE!U>`L``00E#@``!#D!``#M7=V7HDBR?[_GW/_!K7V9?=`2$#_Z3-^] ME%H]GK7556MV^^D>"E*+.P@.8'4Y?_UF\B4J2(($7ST/,U5M(1'QB\C(R,C( MR)___K%3&^_(,!5=^_S`M-H/#:1)NJQHV\\/+ZNFL!I.)@\-TQ(U651U#7U^ MT/2'O__/?__7SW]I-A?'[]__][: MR5O;?8YY<+]'6)`M_YLV M1[JQQ<^U^4?GC_ZCA.09C>^<_2PS&`P>[;]ZCUX]&7PO]^CQ[K_95,+>BY]E M'O_]=;J2WM!.;"H:@5XBWS*53Z;]X5271,O65RRQ1N03Y%]-[[$F^:B)H>>8 MUH:I5C'B;;1C9W- M.!;&?O>;@3:?'X@6FYZ*"/F_VI_((E*\!ZWC'AN>J>SV*D;B,0/VGD25P+IZ M0\@RJ?C!.+WEQ,]"-#!R;\@BS](RMX=C;F6)%B+*-.>;^1X9MA+-%TT\R(J% M9"H.34O/B<,A5M2SJG]/S*"T@6-P)EH'`P7APP-C==CM1.,XWZR4K:9L\#?Q M>)$D_8`'C+9=Z*HB*8C..C7=-$5`@"?:.T97-XY4W"CX:3A>%H:.4;2.Q+7\ M?E#V1.]4;.T-]#L<6TND8B.4\>"UCFM#U$Q1LA5-Q9JQMPPXUJ:ZMETC8S=" MKW1(J9;\"CE:=>FW^9X>'>P\)$!V1!5-$9X&7T7IMX#FW+&J;>T_TC&J6KI: M2B\R0I:HJ)3.!/MJ4RZE&/9/.B>DB5@,"I>(O8*)/8C-R!1_X'U!L53\#1R. M-9H-+YH)_HHCXH83VC1"8ALB:*;!DB,`^K"0)B,W1/-$4'7)?4H57Y'Z^0%_ M\'^W7BJ\FI:!K;S%<4P'A^MLJTN#*=4[SQE62;"J&Q[D5!RO\3=;##_@>R&< M!8-V$TFMK?[^*".%!/D,^85PS33;C!O+_A5_=/9B*O:"-B$8'JL;0]_=A:VE MQPBJ&S(R['487HCM#44W\+NQ$3XT#B;F5K=]YBDF%`WIRL[.PWSWB<>]'5(V MI3=%O1C8^`DJY0B889DP_:R*6\QTOS_(2#MG;RZ#>J)%=?7#EE`_GLP+A-G" M8LLC'(T0XVIW,QY%9Q3*H*]XT5V]<274FR/P$FT5(J=FS<2=S3O'9J2V,`)E MT%JLX*[2.J55VA"_Q1#5"9Z0/_Z!CC;S7*9:NZ!0'K7=$MW5&U]"O0T/!GG% MLV+B..P;$HV@LVAGI+HH(F70'A4`K@*[)52@)_Y)@&?\B6D'45DYS`@:95`? MC?BN]GHEU)XC\K.B(F.(C6ZK&X[GR&KDA;R_#%J+$]O56+^T&AOJNYVNV6F; MU1M^ISD_6/:6$%Z9VY)DM5"+)U<>?5*#XJIW4$+UGOL3)WX^>92L8IE(*F50 M)AT$OE/EB]#ASX^AF:H$22RVT6SXFR3X]R=A*LR&X\;JE_%XO4J5M`K=0DN< MI?*9FF^>%0V_4,%*T$WE3'MLVUZ`]Z)-<2.:KS:X![.Y%<6]8X](M4SODTO# M=#^F8B!]2DLP38S.21">:8-)JI(KXJ*H8&V>EL,B^\Z2H6U"2[5-;1!X)I.VX%Q`AHN2C> M/-+@553^+2_#<9=GONB=?B\/2[D@F][=S70+F0OQ*+ZJR'UIJ]_CNV!"A!#, MQ+(3Z,2SYQC9:^GS@C(']K\):JIHFLI&0;*'!<,-V'P,(8:3,AA($K!JZ?3< MK=W+`<-P_0$#%R&%$BW*'B@@*"J5"JUZXX!??848L?IV!U+[X70+-``*((K* MQH+:P'BW5_4C\OQ@.`0LW%HIEGY1-I$,F*)RO:"VL18_K@(I++2S+PAB#2$4 MB])_G/!^KCCG1%3!*R"&K\H2*&3$=MM]-D\AT7=T2 M57K;G5MOR!BY!(;X/\4ZN6JVTX9;P-^@7)3WH@7#K\>IJ!=+`%W"7&#T4`H! MOY8YA8#D,UV3+H1GV%XN*;%KTEF/J?L-XS8\M4P;),8/?,Z]/\L>)VBKW^8[ MN"?[@GL+9-<),$8*H9BU/=#$?;X-Q"!0RQ@Y>BOI!!T! M`6[VH.&@2+-(BE`MH^6PY7A`?+PB9_A[OAD/1:!0D6@Y61#D#>6U^!&.0)<#3!K%42_2TR5!INHYV5#3 M"!3I_RJJ!]3BR7EV*%.XI)91D25]?L`_YG5#[%H&Q((L*P[?"U&1)]I0W"O8 MAP1P:'4&#)P3B*=?F"TD@Z:6`8*,X^$V-0R(*;`#2:$A-@YN'[G$]KH!EH;2#0/QM$9\DRGTP4L M2J!B(B^;OPZ44V!4R\B9`KS.C0.`Y3+\,^4Y80_#,FT.3HIKBGF9=.?J'&.< M]"5/?P\<^]70UBY[O,."L<`\Y.8(T'9(1G[L7/J*U`ZG6^[C"':/---&U!6^ MRW98N.$>3;BX84\)AC_ZR[FX3SOZG2.FEP52I#P9\EDI#R3G:H9LCRI._T6=`C,)&4BS`` M6B1JN>KT>RICF5N]`0-W.#)(J0@U1TE:D355,K4N#+07%7G\0>9C_PS'H,/! M;;6&DBQ"T;&REWP5DD[C@5T6!Z^`$^NR?#^/K:=+PL5,YU0X5&11DG!.OPD5 MS$HTXU#T(@ICVAW`!&'>L>?UVOF&N!4Y5IELV4SNQ1`TF?P@"\1W4<6LF((U M%`WCJ&A;=Z.P,X`[=4O%0A&>*S$VM=Q$M>NB7,]]763``]>/B8:#3"P^H?).H7DRA&II^.=Y MB&!Y3`?P`$84U2+-@0:)6N9DZ/""B86`G%_H:[$4+`<8DX82S=&BK^,\"A@J MDEZ*C/?HHJ'H+I2A(7%8U%1+[^_=)[901:>+K'>I&,E6#;H=R+Q--.4,P^!X MQ=-"4'77GQ5>U+-K13Q+FES'%4J0B8*LLAMXG<\-`*=RAPKDV(U*9)Q+5I', M^M6,=G^G:^YFI^O&3PMA.9ZM?QFO)T-A^C=/A/2=KT,O:_VS#?;%X%-5_3O! M[%DW1OKAU=H)MIID:MEJ'96G(PI82B)&/AW M%=EP:K*PTPU+^S=B@0S[VAER7)D'W+*) MYZ!XRTD*4T6BX]2VXMQ')!RL-RS9'TAN\7T6;KJ[0;A4IG$+E5K6I5S)/C'- M@R,WW$(B@F@)+>$:C5I6IMR\IXSO<[G,'3#WN&5K#Q&X5*08)&&/[>!I(4=\ M>X:$.QL?0K%X&XB#H:B;&>_5_?UIM,Y%&FVU%M;CK^/9>M68/S?FB_%26$_F MLU7CIY>9\#*:K,>C=,DTGX@YW\SQZM'FR'S1Q(.,5P,7X"3(J$TT3`+Y;_=- M80!8Q1)!,WW>;"6JR%RB=Z0=2&5\BVES';A`[H):)L.35@W^B;8;$MN\>:J;9JO? MA^PN$$(Q#\,-J2V)$;TB2:EDA<0S7=//Y78';K`?%=QE+;'D"_%AB4"I9?[I M-`2>,8I#7<-0'#`:IZ#.Z;'A/&??8R#Z^X(5!B4/.N7MC<"7CT%HY(N"UBD=4:K&)<7+6Y%$GC)?)37 MKLW;WWH2347":ZB1HA[(+JE_61`/V/60DHE"`K(4`/F&PO)E-I1D8=F_D+)] M(P*_XZE_BV:'W2LRYINKE+>+RT@Q)54W#S@V(#'`:2G.U(6HFEAM+\D54-.*RW09\X@>9G`'K_Q)PDHE! MI5@M^P4Q*4&K99Z4'D>8N#:;M$-$I.XLK=P7MGJ]7A?-$4*P M:-W'8%#+-"D]7$!+=;AY+/+5Y`H2R.Q#%-V<[3LD*4&%2"V3J&13=[XA+23, ME:[*+7[0A[QXXXQ8)GJGWY@/[F-'B%S+D'R%[)V!+TC#)JZ2LR#R3M$4`I.E MO/NFSK2[';BPAHZ)@BPB!4(E#WG37L!A(DR%]%@:H7>DZO:I(%]\A@7L=GN3 M=D%V08]'+6-?FK-D+8;CNZ#-=V)9*,@X$J-3RS@Y%C>86/*NPC@J0;#J6!:P MF.&27CY6?!W[WI:[EC$O[6:`O1=%W'P'KDPJ$2^9V`C43E/2K99K=&L9?4?` MX:)[?:0%`\+!;04GY*;*!D>%<"W#^-`]]1;/]N"VZT))9F(]J2LH;E88!-&H MI=NYE-J%J]7M<7`G4R*(EM,.0A"IJC>X_QP9?_,TY,M+' M^5G5OV=SC(R<$40CY/R<:'[-OWN1ZFD>Z<*655+R<5?%Z`6-ZTY#+;[+=?(4 M\YJ%K.I\4NLU4%V:#*^23PAIM[.O* M[$SD_*H8C,$@5^]Y3K[$AG(#IY+GAK.S%>]BF(##> M[57]B-`2V4WUIHKXJJB*Y40C?)Y&$\U)>>V'#KV2GRO+RI3P8#(.%R#T`-O- MT7!07M.YC59%CJK=:S)VS:_;LSB(!,-#MK>AYJ.\UD,#G+\J*.=5WQF['3NR M]>9QIL,#7IY,Q4-Y;2<.,-=N!C7W/=YQ$Q<"4G+.=P$WL&@X**_1W$;+RV>V M:V4SY-9:T7Q;&/J[(B/YZ?ABDG6TVUU0VPJ2I;S;?C=0`42 M[<6CNXWBAK<+T;".(_1*FK&U6<`LW2W:V93R9Z'94PTG+5)^VK^<,W+:5$L0 M@)EN!685+#S@2EJM/M\%K`:E9Z3HX1/: MTB4-B"7?%DG9="\]L#!=^'(<3)B(A)!L]S(C3=O)=4CS3:!_=VO`LZ"W--XF M7_3(";O.D1ZPDA*UKMOQBR#A57T'P>5,TS.=#'IG'R/A!JPSV!RANYPW&[TN]8%Z?>#8J#H"\(& MO4$;3FAZ1B#'5S*E^\X\'8@E=^L9KRIHH,TS#H(93H%IG?3)GV\N[TG#\WH/ MKH-(//VB1\_-2"@>LI*OQ'.?@7)=DH(,&7I:9`DY*(/018\AZG5X'(BU7(=? MS<9+C(&A2'@2&^))6=DH6%_(G&]&:$]N(2)S,F"]?%)VBC8NBO`F":`US:Q' M`.SOYX4##%)N-[2N:\)&D/__X+2"PYY@B21= MDQ1[O_F$P5I/BBW7Z\%%_A`$X0#P.L-;E'.Q&:2B9;<.,+\>]6CAUPQI.Z0O6EK(2GYB$W!V9T!R9WF."`&[0L,X8J_WJZ@>4(OO M.#MU,))1\9#C&+A*^B4'J1KG,O?V*,:@&%;60Z"<$6X60P"F(WC)AL!UL_#$ M(%7C/*DS!,9:@G3WZK#?JS:$HNI!.-$VNK%S0#^!V85K(4_)1('KOA0PU?(\ MJ2<[N9\6_WI:HVERR-KBU/4QT+.6@^N[>B]W!1I8EL#ZM]C5S?(6HB*/#@:& MXAL2C6?=.$G/,9VPAN4&VAO$6MAVW[45\LGMEV5C!6G]:M`@Z.2M>E8I7-TZ M'@&&B3F?;^RR:6%'VH:0BFHD8\1X%O"T\6WBF=A']H[TU/N;&KE:6H[7?2E8 M_DSZH;D_)U4\E?M63IA&*_W%NMLAGR_[>6S'*6AMT=U(^ M7_A3=1>H90X?%'>8*L'"2E5"`?1N_'0F'>^R3\#^"=<$R^__K@LE8V`K^72: MMA0R_"A9JSOHPAW0"Z=9?INYSAC%@E?+Z/O4M$:16SS/P"W2@I0RB\F39!@N M+]&^%+FF^O5[VMKR,NU!'[1M7)!:P6J.EKSD$P#8'1-,FVDT&Z?E*?['3%B_ M+,?D@HGY8KP4UI/Y;-409J/&ZN7K5V'YC?QE-?DRFSQ/AL)LW1"&P_G+;#V9 M?6DLYM/)<#)>>8(FNH-B)EJ8@?G&==:Z1NX_6QUV.]$XSCK,DZ7F["` MYP8S8?&.>/,>\H&T!U;E+0VNL=*>5-)<@>FT!W!5B7F+DXG#`[)2/S8N4L55 MG6/O=[SLI>.=S'X=S];SY;=4[M.[$^.8VAGZ;PC)5G8X%K++8R3A](XKY*4! M"VQWF%SER=8A)-+4*?RA!.3''9+QB<=J6Y'FX+'DL^?3#-O+5H5;+L(!KER2L9#*L4V@UT*HA'6P_ M[F#O7`[VY7@JK,>CQD(@(WZ]%&8K86@O?U(-^&!;T[4A:B96(%G5I![T42\\ MN?X.X#'F..KIAWS4F\-,=S#HY2\BU'A/KM!3;]14D/VX@YV_'.S3^>Q+ M?FV,QD_I9O2IKFW7R-A==UA.,*C)E\.C.+C$:SC-]`/X_'TGR^LR'%QCR0BB MF0Q,6J6W MDI(;T]X#>B5[0%ZGE8`Q\(`C]"[>[AC)M'2?@G2#D25H<E>^1IB.F].QL!H_"=CI!()Z_$=W?V/VI6$_D5U'Z M+1"*^5O.T^LCDPFF%3<<3I"B@^:FVV2710U9(D&.OU&IOBIYUN M'W/M0S!(71P1%@'W5NK8"(I\/F!LAQ.P0)&>J))F#7E'9%J37<4M9AVOPNX$Y:< MHRH8W+U`UW*5YJ\B+L==;]"!6Y5%4:V"&=$@5LM\U0M>*FS&IJ7LR#51+89G M`&^]/B=6!;NX`4\M%^&KPZN)?C]@^F,R(,SPZ9O``%?D1<5#%8PG.9A579_' M5S#)@H)9$3=66"@8UI8V(E2^^;(J&`4]&E7M/AN=K''_0OY'BB/Q)_\!4$L# M!!0````(`"-Q9T&B@7[YH@8``,LT```1`!P`?.=905'?_8F(\NJ;BL_Z-6!<^"\1M?RI5+YJ6U?7EX>Y$=7,Y$> MQ#R[?IH+GA0Q21!8'G:=0\OI6H?'Z!?T^M0Y0<%%J7@E3V6\)!E&"HL%46.< M$9GC&`)JN!>9S$A"8YR67I740]G:;?>G(P2I(+EXFMO23D^-WC`TD^5B`:K=(YLRC6-,:GW&&2NRNPT2)6RU MRHD-2A9H$4'C:[O'C6X:7,D;^I='=4R._>?%*#2X=@!EA#3.F#&NL(*5-*)* MF.>4S7DE`5E*V<=3_6>&)9F0.;HR$L%3\@`$^K$-.,9%:D88K1UT*@]+0>9G M';T&5@WP7V!Q`%.I5?0*9Z1=$ND0/=_C%0NB(37^RG4`I/_!&`ZP@B" M1_IB.AEND\`,9CV;5=)ZV;\*&P(,0:@E45KW)C7R=JEQ]"`UT/>!._'& MT7LO&O;=T0][JNP"508\+O1RN2SQF*)J-80-@LC,M!MD23"A[9+%`8+4@S+B.BSUTPUB)"J9-8N$8XWB3#RQ^^LR)M+@*Z*3DLZTR31&,WFDX\Y)\C/_`F;C3TQR%RQP,43B\NW,D'_20>WLJ8T/=[F)=.P2;YN)2X5?(Y7X5\>\Z]<,X- MB,(TO4$]2'LR:9-ZK[I?AWSH^RKZ?>K;"1H&Y?>JE3Z^?2IHKH]0#6(!"I_: MS6A'FZ0*)II,T0=#).^WZ3"X@,WZGAV[P(X)`5!)$F!@2"0PDS@VJ:K!$)$K MT2Y#7FTR9.*-W,@;H,#5-(DF[CAT^R;Y[%FR"RP)<4I&!!9VAN./#9I4I8TM MS,,&9V2J>-HN:7[<)$WHCCQKY+FAUW/[OS99`P^K\@5UR6CL:;03-*J__$I_ MWL=R>9[R2SEEN$BHTC_+KNFCXGF[WQ*/-SX\AQ$D'%V&0KVEZ;OA>W0^\O^` MWWTHPD0]YQ0_VA6B'R+#.(.MS MU=TIA+?\V]6K!U-(X[RT3R'MLN:-O=&84@INMJ_HYA6:Y5PHQ.[L&;JO1Z=L M-QKQV/AZP$3?6;6=I466*:^8],8K:[N5&,<=R9MP5TEI@ MG.LF*\?J.I9NL[HG#!/"G88V296L)=;:U?-`N=U>M0TNFU8:E1.-BO/Z2\-H MMH8]+13.QL^/I@FU=B=;6B3CZSFKU.3@L;E+U-:DK0TT$L=/&U*2^&#!/]L) MH5M#L&FC+[Z8F7H1RT+(R`*;@K?-[%,A;EC=1P9=.$^KUDD3REFGAR6%6KOQ MB7)5_HW(E>JEL#U;U]V_MC5@-(4:HKNME"CTS\.ZJ?(42CKE262:LY)"5#T& MLIA)156A[]X)7N1GG5(=:G[6064O5]EE>:KJ(8;P3#NZM]OS[O;(![#01Y8` MTV10")C7!X+%.1(1_1>8%ZX_4//_;/?0O<%(A`NL2`]O:[-5]X5`K.%T>NMUBH! M7IF7X1*+9$(T'&UL550%``/1L9I0=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`(W%G0>N\NV!P"P``!(\``!4`&``` M`````0```*2!)1\``')E<'(M,C`Q,C`X,S%?8V%L+GAM;%54!0`#T;&:4'5X M"P`!!"4.```$.0$``%!+`0(>`Q0````(`"-Q9T'2+%_6=3P``/%E`P`5`!@` M``````$```"D@>0J``!R97!R+3(P,3(P.#,Q7VQA8BYX;6Q55`4``]&QFE!U M>`L``00E#@``!#D!``!02P$"'@,4````"``C<6=!)0R*ZOX7``!"90$`%0`8 M```````!````I(&H9P``&UL550%``/1L9I0 M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`(W%G0:*!?OFB!@``RS0``!$` M&````````0```*2!]7\``')E<'(M,C`Q,C`X,S$N>'-D550%``/1L9I0=7@+ B``$$)0X```0Y`0``4$L%!@`````%``4`OP$``.*&```````` ` end EXCEL 9 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\Q9C-B-C0Y9%]A8C)D7S0W.3E?.60X9%]D.&$T M9#%C.60P.&$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DY!5%5215]/1E]/4$52051)3TY3 M7T%.1%]354U-03(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I3 M='EL97-H965T($A2968],T0B5V]R:W-H965T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q9C-B-C0Y9%]A8C)D M7S0W.3E?.60X9%]D.&$T9#%C.60P.&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO,68S8C8T.61?86(R9%\T-SDY7SED.&1?9#AA-&0Q8SED,#AA M+U=O'0O M:'1M;#L@8VAA2!);F9O2!296=I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M,C`Q,SQS<&%N/CPO'0^43(\2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^4VUA;&QE3QS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\Q9C-B-C0Y9%]A8C)D7S0W.3E?.60X9%]D.&$T9#%C.60P.&$-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,68S8C8T.61?86(R9%\T-SDY7SED M.&1?9#AA-&0Q8SED,#AA+U=O'0O:'1M;#L@8VAA2`R.2P@,C`Q,BP@2`R M.2P@,C`Q,BP@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6%B;&4@+2!C=7)R96YT('!O6%B;&4@=&\@'!E;G-E"!L:6%B:6QI M='D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$6%B;&4@+2!L97-S(&-U6%B;&4@=&\@2`R.2P@,C`Q,BP@2`R.2P@,C`Q,CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q9C-B-C0Y9%]A8C)D7S0W.3E? M.60X9%]D.&$T9#%C.60P.&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO,68S8C8T.61?86(R9%\T-SDY7SED.&1?9#AA-&0Q8SED,#AA+U=O'0O:'1M;#L@ M8VAA'!E;G-E'0^)FYB'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XS,"PU,S,\&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PY M.#D\'!E M;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-BPR-3,I/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S"!L:6%B:6QI='D\+W1D/@T* M("`@("`@("`\=&0@8VQA6UE;G1S(&9O2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M/B@T,C'0^)FYB'0^ M)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6%B;&4@=&\@"!B96YE M9FET6UE;G0@87)R86YG96UE;G1S/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'1087)T7S%F,V(V-#ED7V%B,F1?-#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$"<^/'-T M"<^)FYB"<^/'4^5$A%($Y!5%5212!/1B!/4$52051)3TY3/"]U/CPO M<#X@/'`@7-T96US+"!);F,N("AT M:&4@(D-O;7!A;GDB*2!D97-I9VYS+"!M86YU9F%C='5R97,L(&%N9"!M87)K M971S('!R;W!R:65T87)Y(&UE9&EC86P@9&5V:6-E"<^ M)FYB"<^5&AE(&%C8V]M M<&%N>6EN9R!U;F%U9&ET960@9FEN86YC:6%L('-T871E;65N=',@87,@;V8@ M075G=7-T(#,Q+"`R,#$R(&AA=F4@8F5E;B!P2P@=&AE>2!D;R!N;W0@:6YC;'5D92!A M;&P@;V8@=&AE(&EN9F]R;6%T:6]N(&%N9"!D:7-C;&]S=7)E2!A8V-O=6YT:6YG('!R:6YC:7!L97,@9V5N97)A;&QY(&%C8V5P=&5D M(&EN('1H92!5;FET960@4W1A=&5S(&]F($%M97)I8V$@9F]R(&-O;7!L971E M(&9I;F%N8VEA;"!P"<^)FYB"<^ M26X@=&AE(&]P:6YI;VX@;V8@=&AE($-O;7!A;GDF(S,Y.W,@;6%N86=E;65N M="P@=&AE(&9I;F%N8VEA;"!S=&%T96UE;G1S(&-O;G1A:6X@86QL(&%D:G5S M=&UE;G1S("AC;VYS:7-T:6YG(&]F(&YO2!T;R!P2!T:&4@0V]M<&%N>28C M,SD["!M;VYT:',@96YD960@075G=7-T(#,Q+"`R,#$R(&%N M9"`R,#$Q(&%R92!N;W0@;F5C97-S87)I;'D@:6YD:6-A=&EV92!O9B!T:&4@ M'!E8W1E9"!F;W(@=&AE(&9U;&P@>65A2!A;F0@;6%N86=E M;65N="8C,SD[7-I6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@ M+SX@/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^26X@2G5L>2`R,#$R M+"`Q+#0V-2PP,#`@65A6QE/3-$)TU!4D=)3CH@,'!X)SX\=3Y)3E9%3E1/4DE%4SPO=3X\ M+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S M='EL93TS1"=-05)'24XZ(#!P>"<^3W5R(&EN=F5N=&]R>2!I;F-L=61E2!U"<^/'4^55-% M($]&($535$E-051%4R!)3B!42$4@1DE.04Y#24%,(%-4051%345.5%,\+W4^ M/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^)FYB"<^5&AE('!R97!A2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,@*")'04%0(BD@ M2P@86YD(&%C8W)U86QS+CPO M<#X@/'`@"<^)FYB"<^5&AE($-O;7!A;GD@:&%S M(&5V86QU871E9"!S=6)S97%U96YT(&5V96YT6QE/3-$)TU!4D=)3CH@ M,'!X)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SX\=3Y% M34521TE.1R!!0T-/54Y424Y'(%-404Y$05)$4SPO=3X\+W`^(#QP('-T>6QE M/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=) M3CH@,'!X)SY-86YA9V5M96YT(&1O97,@;F]T(&)E;&EE=F4@=&AA="!A;GD@ M;V8@=&AE('-T86YD87)D6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^ M(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SY4:&4@0V]M<&%N>2!L96%S97,@ M86X@86ER8W)A9G0@9G)O;2!A($-O;7!A;GD@8V]N=')O;&QE9"!B>2!T:&4@ M<')E'!I2!I6UE;G1S+CPO<#X@/"$M+45N9$9R86=M96YT M+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2D\8G(^/"]S=')O;F<^/"]T M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L"<^/'4^5$A%($Y!5%5212!/1B!/4$52051)3TY3/"]U/CPO M<#X@/'`@7-T96US+"!);F,N("AT M:&4@(D-O;7!A;GDB*2!D97-I9VYS+"!M86YU9F%C='5R97,L(&%N9"!M87)K M971S('!R;W!R:65T87)Y(&UE9&EC86P@9&5V:6-E'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@ M+2T^#0H\9&EV/B`\9&EV('-T>6QE/3-$)U=)1%1(.B`W,C!P>"<^/"$M+5-T M87)T1G)A9VUE;G0M+3X@/'`@6QE/3-$)TU!4D=) M3CH@,'!X)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SY4 M:&4@86-C;VUP86YY:6YG('5N875D:71E9"!F:6YA;F-I86P@6QE M/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=) M3CH@,'!X)SY);B!T:&4@;W!I;FEO;B!O9B!T:&4@0V]M<&%N>28C,SD["<^)FYB"<^5&AE(')E&AT;6PQ+71R86YS:71I;VYA;"YD M=&0B("TM/@T*/&1I=CX@/&1I=B!S='EL93TS1"=724142#H@-S(P<'@G/CPA M+2U3=&%R=$9R86=M96YT+2T^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SX\ M=3Y%35!,3UE%12!35$]#2R!!5T%21%,\+W4^/"]P/B`\<"!S='EL93TS1"=- M05)'24XZ(#!P>"<^/&)R("\^(#PO<#X@/'`@F%T:6]N+B!4 M:&4@=F%L=64@;V8@=&AEF5D(&EN M=&\@;W!E"<^/'4^24Y6 M14Y43U))15,\+W4^/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^/&)R M("\^(#PO<#X@/'`@'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^ M#0H\9&EV/B`\9&EV('-T>6QE/3-$)U=)1%1(.B`W,C!P>"<^/"$M+5-T87)T M1G)A9VUE;G0M+3X@/'`@&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*/&1I M=CX@/&1I=B!S='EL93TS1"=724142#H@-S(P<'@G/CPA+2U3=&%R=$9R86=M M96YT+2T^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SX\=3Y354)315%514Y4 M($5614Y44R!%5D%,54%424]./"]U/CPO<#X@/'`@"<^)FYB&AT;6PQ+71R86YS:71I;VYA M;"YD=&0B("TM/@T*/&1I=CX@/&1I=B!S='EL93TS1"=724142#H@-S(P<'@G M/CPA+2U3=&%R=$9R86=M96YT+2T^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X M)SX\=3Y,14%3140@04E20U)!1E0\+W4^/"]P/B`\<"!S='EL93TS1"=-05)' M24XZ(#!P>"<^)FYB"<^ M5&AE($-O;7!A;GD@;&5A6UE M;G1S(&%G9W)E9V%T960@=V5R92`D-2PS-S4@9F]R('1H92!T:')E92UM;VYT M:',@96YD960@075G=7-T(#,Q+"`R,#$R(&%N9"`R,#$Q(&%N9"`D,3`L-S4P M(&9O'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQAF5D(&9OF5D(&9OF5D(&9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC'10 L87)T7S%F,V(V-#ED7V%B,F1?-# XML 10 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
 1 Months Ended 3 Months Ended 6 Months Ended
Jul. 30, 2012
Aug. 31, 2012
Aug. 31, 2011
Aug. 31, 2012
Aug. 31, 2011
Jul. 31, 2012
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]            
Shares authorized for issuance           1,465,000
Shares authorized for issuance, per share           $ 0.18
Shares authorized for issuance, period restriction, minimum 1 year          
Shares authorized for issuance, period restriction, maximum 2 years          
Inventory of certain assemblies off site   $ 349,000   $ 349,000    
Aircraft lease expense   $ 5,375 $ 5,375 $ 10,750 $ 10,750  
XML 11 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
BALANCE SHEETS (USD $)
Aug. 31, 2012
Feb. 29, 2012
CURRENT ASSETS:    
Cash and cash equivalents $ 1,684,369 $ 1,757,223
Certificates of deposit 255,356 255,228
Accounts receivable less allowance for doubtful accounts of $21,456 and $17,718 for August 31, 2012 and February 29, 2012, respectively 962,154 884,727
Inventory 1,251,385 1,167,456
Prepaid expenses 158,369 188,902
Total Current Assets 4,311,633 4,253,536
PROPERTY & EQUIPMENT, net 845,360 498,940
OTHER ASSETS:    
Patents, net of accumulated amortization of $109,838 and $107,640 at August 31, 2012 and February 29, 2012, respectively 23,315 24,513
Security deposit 30,968 28,156
Total Other Assets 54,283 52,669
TOTAL ASSETS 5,211,276 4,805,145
CURRENT LIABILITIES    
Note payable - current portion 2,157 2,077
Notes payable to related parties - current portion 42,675 41,417
Deferred capital gain - current portion 22,481 22,481
Accounts payable 112,504 199,527
Accrued expenses 107,547 153,800
Accrued payroll and related taxes 56,540 41,551
Accrued tax liability 214,092 98,000
Total Current Liabilities 557,996 558,853
OTHER LIABILITIES    
Note payable - less current portion 375 1,474
Notes payable to related parties - less current portion 416,175 437,832
Deferred capital gain less current portion 123,656 134,895
Deferred tax liability 121,363 121,363
Total Other Liabilities 661,569 695,564
Total Liabilities 1,219,565 1,254,417
STOCKHOLDERS' EQUITY    
Common stock, $0.01 par value, 50,000,000 shares authorized and 38,936,667 and 37,471,667 shares issued; 36,661,667 and 35,196,667 shares outstanding at August 31, 2012 and February 29, 2012, respectively. 389,367 374,717
Additional paid-in Capital 3,512,294 3,263,244
Retained earnings 495,750 54,767
Total Stockholders' Equity before Treasury Stock 4,397,411 3,692,728
Less: Treasury Stock, 2,275,000 shares at cost at August 31, 2012 and February 29, 2012 (142,000) (142,000)
Deferred compensation cost (263,700)   
Total Stockholders' Equity 3,991,711 3,550,728
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 5,211,276 $ 4,805,145
XML 12 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 6 Months Ended
Aug. 31, 2012
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

THE NATURE OF OPERATIONS

 

Repro-Med Systems, Inc. (the "Company") designs, manufactures, and markets proprietary medical devices primarily for the ambulatory infusion market and emergency medical applications. The FDA regulates these products.

 

BASIS OF PRESENTATION

 

The accompanying unaudited financial statements as of August 31, 2012 have been prepared in accordance with generally accepted accounting principles in accordance with instructions to regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial presentation.

 

In the opinion of the Company's management, the financial statements contain all adjustments (consisting of normal recurring accruals) necessary to present fairly the Company's financial position as of August 31, 2012 and the results of operations and cash flow for the three-month and six month periods ended August 31, 2012 and 2011.

 

The results of operations for the three months and six months ended August 31, 2012 and 2011 are not necessarily indicative of the results to be expected for the full year. These interim financial statements should be read in conjunction with the financial statements and notes thereto of the Company and management's discussion and analysis of financial condition and results of operations included in the Company's Annual Report for the year ended February 29, 2012, as filed with the Securities and Exchange Commission on Form 10-K.

 

EMPLOYEE STOCK AWARDS


In July 2012, 1,465,000 shares were authorized to issue to employees as share compensation valued at $0.18 per share, the market value on the date of the board authorization. The value of these shares will be amortized into operations over the one to two year restriction on the shares.


INVENTORIES


Our inventory includes $349,000 of certain subassemblies which did not meet our specifications and were rejected by us and returned to the vendor for correction or replacement.


USE OF ESTIMATES IN THE FINANCIAL STATEMENTS

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Important estimates include but are not limited to, asset lives, valuation allowances, inventory, and accruals.

 

SUBSEQUENT EVENTS EVALUATION

 

The Company has evaluated subsequent events through October 15, 2012, the date on which the financial statements were issued.

 

EMERGING ACCOUNTING STANDARDS

 

Management does not believe that any of the standards adopted by the Financial Accounting Standards Board that have been adopted but are not yet effective will have a material effect on the Company's financial reporting.

 

LEASED AIRCRAFT

 

The Company leases an aircraft from a Company controlled by the president. The lease payments aggregated were $5,375 for the three-months ended August 31, 2012 and 2011 and $10,750 for the six months ended August 31, 2012 and August 31, 2011. The original lease agreement has expired and the Company is currently on a month-to-month basis for rental payments.
XML 13 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 14 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)
 6 Months Ended
Aug. 31, 2012
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
THE NATURE OF OPERATIONS

THE NATURE OF OPERATIONS

 

Repro-Med Systems, Inc. (the "Company") designs, manufactures, and markets proprietary medical devices primarily for the ambulatory infusion market and emergency medical applications. The FDA regulates these products.
BASIS OF PRESENTATION

BASIS OF PRESENTATION

 

The accompanying unaudited financial statements as of August 31, 2012 have been prepared in accordance with generally accepted accounting principles in accordance with instructions to regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial presentation.

 

In the opinion of the Company's management, the financial statements contain all adjustments (consisting of normal recurring accruals) necessary to present fairly the Company's financial position as of August 31, 2012 and the results of operations and cash flow for the three-month and six month periods ended August 31, 2012 and 2011.

 

The results of operations for the three months and six months ended August 31, 2012 and 2011 are not necessarily indicative of the results to be expected for the full year. These interim financial statements should be read in conjunction with the financial statements and notes thereto of the Company and management's discussion and analysis of financial condition and results of operations included in the Company's Annual Report for the year ended February 29, 2012, as filed with the Securities and Exchange Commission on Form 10-K.
EMPLOYEE STOCK AWARDS

EMPLOYEE STOCK AWARDS


In July 2012, 1,465,000 shares were authorized to issue to employees as share compensation valued at $0.18 per share, the market value on the date of the board authorization. The value of these shares will be amortized into operations over the one to two year restriction on the shares.
INVENTORIES

INVENTORIES


Our inventory includes $349,000 of certain subassemblies which did not meet our specifications and were rejected by us and returned to the vendor for correction or replacement.
USE OF ESTIMATES IN THE FINANCIAL STATEMENTS

USE OF ESTIMATES IN THE FINANCIAL STATEMENTS

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Important estimates include but are not limited to, asset lives, valuation allowances, inventory, and accruals.
SUBSEQUENT EVENTS EVALUATION

SUBSEQUENT EVENTS EVALUATION

 

The Company has evaluated subsequent events through October 15, 2012, the date on which the financial statements were issued.

 
LEASED AIRCRAFT

LEASED AIRCRAFT

 

The Company leases an aircraft from a Company controlled by the president. The lease payments aggregated were $5,375 for the three-months ended August 31, 2012 and 2011 and $10,750 for the six months ended August 31, 2012 and August 31, 2011. The original lease agreement has expired and the Company is currently on a month-to-month basis for rental payments.
XML 15 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
BALANCE SHEETS (PARENTHETICAL) (USD $)
Aug. 31, 2012
Feb. 29, 2012
BALANCE SHEETS [Abstract]    
Accounts receivable, allowance for doubtful accounts $ 21,456 $ 17,718
Patents, accumulated amortization $ 109,838 $ 170,640
Common Stock, par value per share $ 0.01 $ 0.01
Common Stock, shares authorized 50,000,000 50,000,000
Common Stock, shares issued 38,936,667 37,471,667
Common Stock, shares outstanding 36,661,667 35,196,667
Treasury Stock, shares 2,275,000 2,275,000
XML 16 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
 6 Months Ended
Aug. 31, 2012
Oct. 12, 2012
Document and Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Aug. 31, 2012  
Entity Registrant Name REPRO MED SYSTEMS INC  
Entity Central Index Key 0000704440  
Current Fiscal Year End Date --02-28  
Document Fiscal Year Focus 2013  
Document Fiscal Period Focus Q2  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   36,661,667
XML 17 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
 3 Months Ended 6 Months Ended
Aug. 31, 2012
Aug. 31, 2011
Aug. 31, 2012
Aug. 31, 2011
STATEMENTS OF OPERATIONS (UNAUDITED) [Abstract]        
NET SALES $ 1,951,608 $ 1,362,217 $ 3,695,773 $ 2,856,187
COST AND EXPENSES        
Cost of goods solds 666,235 493,064 1,303,597 1,033,249
Selling, general and administrative 663,432 656,338 1,545,202 1,243,116
Research and development 37,015 9,969 75,390 22,696
Depreciation and amortization 42,933 23,959 83,470 46,278
Total Costs and Expenses 1,409,615 1,183,330 3,007,659 2,345,339
Net Operating Profit 541,993 178,887 688,114 510,848
Other Income/(Expenses)        
Gain (Loss) currency exchange (3,572) 1,375 (6,585) 11,266
Interest Expense (7,179) (7,823) (14,386) (15,899)
Interest and Other Income 1,198 24,900 2,932 30,342
Total other Income/(Expense) (9,553) 18,452 (18,039) 25,709
NET PROFIT BEFORE TAXES 532,440 197,339 670,075 536,557
Provision for Income Taxes (181,796) (79,266) (229,092) (220,525)
Net Income $ 350,644 $ 118,073 $ 440,983 $ 316,032
NET INCOME PER SHARE        
Basic $ 0.01    $ 0.01 $ 0.01
Diluted $ 0.01    $ 0.01 $ 0.01
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING        
Basic 35,546,993 36,863,808 35,371,830 36,720,738
Diluted 35,551,934 36,967,975 35,421,253 36,824,905
XML 18 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)
 6 Months Ended
Aug. 31, 2012
Aug. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 440,983 $ 316,032
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 83,470 46,278
Deferred capital gain - building lease (11,239) (11,240)
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (77,427) 105,238
(Increase) in inventory (83,929) (421,743)
Decrease in prepaid expense 30,533 7,488
Increase in security deposits (2,812)   
Decrease in deferred tax asset    18,449
Increase (decrease) in accounts payable (87,023) 13,864
Increase in accrued payroll and related taxes 14,989 19,631
Increase (decrease) in accrued expense (46,253) 77,791
Increase in accrued tax liability 116,092   
NET CASH PROVIDED BY OPERATING ACTIVITIES 377,384 171,788
CASH FLOWS FROM INVESTING ACTIVITIES    
Payments for property and equipment (427,692) (88,676)
Purchase of certificates of deposit (128)   
Payments for patents (1,000)   
NET CASH USED IN INVESTING ACTIVITIES (428,820) (88,676)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from issuing common stock    121,500
Payments to note payable to related parties (20,399) (19,212)
Payments on notes payable (1,019) (946)
Excess tax benefits from share-based payment arrangements    202,076
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (21,418) 303,418
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (72,854) 386,530
CASH AND CASH EQUIVILENTS, BEGINNING OF PERIOD 1,757,223 1,322,250
CASH AND CASH EQUIVILENTS, END OF PERIOD 1,684,369 1,708,780
Cash paid during the period for:    
Interest 14,386 15,899
Taxes 113,000 3,125
Non Cash Activities:    
Deferred compensation cost $ 263,700   
XML 19 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 11 106 1 false 0 0 false 3 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.rmsmedicalproducts.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - BALANCE SHEETS Sheet http://www.rmsmedicalproducts.com/role/BalanceSheets BALANCE SHEETS false false R3.htm 003 - Statement - BALANCE SHEETS (PARENTHETICAL) Sheet http://www.rmsmedicalproducts.com/role/BalanceSheetsParenthetical BALANCE SHEETS (PARENTHETICAL) false false R4.htm 004 - Statement - STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://www.rmsmedicalproducts.com/role/StatementsOfOperationsUnaudited STATEMENTS OF OPERATIONS (UNAUDITED) false false R5.htm 005 - Statement - STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://www.rmsmedicalproducts.com/role/StatementsOfCashFlowsUnaudited STATEMENTS OF CASH FLOWS (UNAUDITED) false false R6.htm 101 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.rmsmedicalproducts.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingPolicies NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R7.htm 201 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy) Sheet http://www.rmsmedicalproducts.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicy NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy) false false R8.htm 40101 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.rmsmedicalproducts.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingPoliciesDetails NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) false false All Reports Book All Reports Process Flow-Through: 002 - Statement - BALANCE SHEETS Process Flow-Through: Removing column 'Aug. 31, 2011' Process Flow-Through: Removing column 'Feb. 28, 2011' Process Flow-Through: 003 - Statement - BALANCE SHEETS (PARENTHETICAL) Process Flow-Through: 004 - Statement - STATEMENTS OF OPERATIONS (UNAUDITED) Process Flow-Through: 005 - Statement - STATEMENTS OF CASH FLOWS (UNAUDITED) repr-20120831.xml repr-20120831.xsd repr-20120831_cal.xml repr-20120831_lab.xml repr-20120831_pre.xml true true